<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion - Simancas‐Racines, D - 2015 | Cochrane Library</title> <meta content="Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion - Simancas‐Racines, D - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009745.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion - Simancas‐Racines, D - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009745.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009745.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion" name="citation_title"/> <meta content="Daniel Simancas‐Racines" name="citation_author"/> <meta content="Universidad Tecnológica Equinoccial" name="citation_author_institution"/> <meta content="danielsimancas10@gmail.com" name="citation_author_email"/> <meta content="Dimelza Osorio" name="citation_author"/> <meta content="Universidad Tecnológica Equinoccial" name="citation_author_institution"/> <meta content="Arturo J Martí‐Carvajal" name="citation_author"/> <meta content="Iberoamerican Cochrane Network" name="citation_author_institution"/> <meta content="Ingrid Arevalo‐Rodriguez" name="citation_author"/> <meta content="Fundación Universitaria de Ciencias de la Salud ‐ Hospital de San José/Hospital Infantil de San José" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD009745.pub2" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/12/03" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009745.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009745.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009745.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Leukocyte Reduction Procedures; Cause of Death; Erythrocyte Transfusion [*adverse effects]; Infections [etiology]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009745.pub2&amp;doi=10.1002/14651858.CD009745.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="kKvAiZoF";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009745\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009745\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009745\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009745\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","hr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009745.pub2",title:"Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion",firstPublishedDate:"Dec 3, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Injuries Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=kKvAiZoF&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009745.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009745.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009745.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009745.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009745.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009745.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009745.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009745.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009745.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009745.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4984 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009745.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/full#CD009745-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/full#CD009745-sec-0105"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/full#CD009745-sec-0015"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/full#CD009745-sec-0016"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/full#CD009745-sec-0023"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/full#CD009745-sec-0024"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/full#CD009745-sec-0051"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/full#CD009745-sec-0097"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/appendices#CD009745-sec-0110"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/table_n/CD009745StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/table_n/CD009745StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/information#CD009745-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Daniel Simancas‐Racines</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/information#CD009745-cr-0003">Dimelza Osorio</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/information#CD009745-cr-0004">Arturo J Martí‐Carvajal</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009745.pub2/information#CD009745-cr-0005">Ingrid Arevalo‐Rodriguez</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/information/en#CD009745-sec-0123">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 03 December 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009745.pub2">https://doi.org/10.1002/14651858.CD009745.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009745-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009745-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009745-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009745-abs-0008">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009745-abs-0001" lang="en"> <section id="CD009745-sec-0001"> <h3 class="title" id="CD009745-sec-0001">Background</h3> <p>A blood transfusion is an acute intervention, implemented to solve life and health‐threatening conditions on a short‐term basis. However, blood transfusions have adverse events, some of them potentially related to immune modulation or to a direct transmission of infectious agents (e.g. cytomegalovirus). Leukoreduction is a process in which the white blood cells are intentionally reduced in packed red blood cells (PRBCs) in order to reduce the risk of adverse reactions. The potential benefits of leukoreduced PRBCs in all types of transfused patients for decreasing infectious and non‐infectious complications remain unclear. </p> </section> <section id="CD009745-sec-0002"> <h3 class="title" id="CD009745-sec-0002">Objectives</h3> <p>To determine the clinical effectiveness of leukoreduction of packed red blood cells for preventing adverse reactions following allogeneic blood transfusion. </p> </section> <section id="CD009745-sec-0003"> <h3 class="title" id="CD009745-sec-0003">Search methods</h3> <p>We ran the most recent search on 10th November 2015. We searched the Cochrane Injuries Group's Specialised Register, Cochrane Central Register of Controlled Trials (CENTRAL, the Cochrane Library), MEDLINE (OvidSP), Embase(OvidSP), CINAHL Plus (EBSCO), LILACS (BIREME), and clinical trials registers. In addition, we checked the reference lists of all relevant trials and reviews identified in the literature searches. </p> </section> <section id="CD009745-sec-0004"> <h3 class="title" id="CD009745-sec-0004">Selection criteria</h3> <p>Randomised clinical trials including patients of all ages requiring PRBC allogeneic transfusion. Any study was eligible for inclusion, regardless of the length of participant follow‐up or country where the study was performed. The primary outcome was transfusion‐related acute lung injury (TRALI). Secondary outcomes were death from any cause, infection from any cause, non‐infectious complications and any other adverse event. </p> </section> <section id="CD009745-sec-0005"> <h3 class="title" id="CD009745-sec-0005">Data collection and analysis</h3> <p>At least two review authors independently performed study selection, 'Risk of bias' assessments and data extraction. We estimated pooled relative risk for dichotomous outcomes, and we measured statistical heterogeneity using I² statistic. The random‐effects model was used to synthesise results. We conducted a trial sequential analysis to assess the risk of random errors in cumulative meta‐analyses. </p> </section> <section id="CD009745-sec-0006"> <h3 class="title" id="CD009745-sec-0006">Main results</h3> <p>Thirteen studies, most including adult patients, met the eligibility criteria. We found no clear evidence of an effect of leukoreduced PRBC versus non‐leukoreduced PRBC in patients that were randomised to receive transfusion for the following outcomes: </p> <p><b>TRALI</b> : RR 0.96, 95% CI 0.67 to 1.36, P = 0.80 from one trial reporting data on 1864 trauma patients. The accrued information of 1864 participants constituted only 28.5% of the diversity‐adjusted required information size (DARIS) of 6548 participants. The quality of evidence was low.<br/> <b>Death from any cause:</b> RR 0.81, 95% CI 0.58 to 1.12, I² statistic = 63%, P = 0.20 from nine trials reporting data on 6485 cardiovascular surgical patients, gastro‐oncology surgical patients, trauma patients and HIV infected patients. The accrued information of 6485 participants constituted only 55.3% of the DARIS of 11,735 participants. The quality of evidence was very low.<br/> <b>Infection from any cause:</b> RR 0.80, 95% CI 0.62 to 1.03, I² statistic = 84%, P = 0.08 from 10 trials reporting data on 6709 cardiovascular surgical patients, gastro‐oncology surgical patients, trauma patients and HIV infected patients. The accrued information of 6709 participants constituted only 60.6% of the DARIS of 11,062 participants. The quality of evidence was very low.<br/> <b>Adverse events:</b> The only adverse event reported as an adverse event was fever (RR 0.81, 95% CI 0.64 to 1.02; I² statistic= 0%, P = 0.07). Fever was reported in two trials on 634 cardiovascular surgical and gastro‐oncology surgical patients. The accrued information of 634 participants constituted only 84.4% of the DARIS of 751 participants. The quality of evidence was low.<br/> <b>Incidence of other non‐infectious complications:</b> This outcome was not assessed in any included trial. </p> </section> <section id="CD009745-sec-0007"> <h3 class="title" id="CD009745-sec-0007">Authors' conclusions</h3> <p>There is no clear evidence for supporting or rejecting the routine use of leukoreduction in all patients requiring PRBC transfusion for preventing TRALI, death, infection, non‐infectious complications and other adverse events. As the quality of evidence is very low to low, more evidence is needed before a definitive conclusion can be drawn. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009745-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009745-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD009745-abs-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD009745-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009745-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD009745-abs-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD009745-abs-0005">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009745-abs-0003" lang="en"> <h3>White blood cells reduction in packed red blood cell transfusions for preventing adverse reactions </h3> <p><b>Background</b> <br/> A blood transfusion is when blood is taken from one person and given to another person. Blood transfusions are given to solve life and health‐threatening medical conditions on a short‐term basis. However, blood transfusions have adverse events, some of them potentially related to an immune system response or due to the transmission of infectious agents (e.g. Human Immunodeficiency Virus). Leukoreduction is a process in which the white blood cells are intentionally removed from donated blood in order to reduce the risk of adverse reactions in people receiving the blood transfusion. The benefits of removing white blood cells with the intent of reducing infectious and non‐infectious complications in all types of transfused patients remains unclear. Removing white blood cells is costly. The USA and UK spend tens of millions each year on the procedure. In the USA, the procedure costs approximately USD $30 for each unit of blood product. It may not be worth spending so much money if there is no clear benefit to patients. </p> <p><b>Clinical question</b> <br/> What are the benefits and harms of removing white blood cells from donated blood for people receiving a blood transfusion? </p> <p><b>Study characteristics</b> <br/> We searched medical journals for reports of clinical trials which examined the effects of removing white blood cells from donated blood. We were interested in finding out whether the removal of white blood cells from donated blood resulted in patients receiving a blood transfusion having few complications such as transfusion‐related acute lung injury, death, infectious and non‐infectious complications, or any other adverse event. We included people of any age or sex, who received a blood transfusion for any reason. The evidence is based on studies retrieved up to 05 December 2014. </p> <p><b>Main results</b> <br/> We found 13 studies which included people who received a blood transfusion during heart or cancer surgery, or because they were injured, had cancer, HIV or sepsis. </p> <p>We found no clear evidence showing either benefits or harms for removing white blood cells from donated blood. For all of the outcomes examined (transfusion‐related acute lung injury, death from any cause, infection from any cause, non‐infectious complication or any other adverse event), there was no sign of benefit or harm. </p> <p><b>Quality of evidence</b> <br/> The overall quality of evidence of the included studies ranges from very low to low. None of the studies included enough people to give a definitive answer about the usefulness of removing white blood cells from donated blood. New high‐quality studies, involving a few thousand people, are needed to enable us to know the true benefits and harms of this procedure. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009745-sec-0105" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009745-sec-0105">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009745-sec-0159">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009745-sec-0105"></div> <h3 class="title" id="CD009745-sec-0106">Implications for practice</h3> <section id="CD009745-sec-0106"> <p>There is no clear evidence for supporting or rejecting the routine use of leukoreduction in all patients requiring PRBC transfusion for preventing TRALI, death from any cause, infection from any cause, non‐infectious complications and other adverse events. The quality of evidence is very low to low. Given that leukoreduction is a very expensive procedure, clinicians and policy makers may need to reconsider whether transfusing leukoreduced PRBC is suitable for all types of patients, especially for patients without a strong indication for leucocyte reduction. In countries where leukoreduction has not been universally implemented yet, selective leukoreduction is an option to be considered until better evidence on the effectiveness or harms of this procedure is available. </p> </section> <h3 class="title" id="CD009745-sec-0107">Implications for research</h3> <section id="CD009745-sec-0107"> <p>Taking into account the inconclusive evidence found in this Cochrane review, further research is needed to assess the relative efficacy, safety and cost‐effectiveness of leukoreduction in different clinical settings and for different conditions. Researchers should consider that premature randomisation is an important issue because it may cause attrition bias and affect the interpretation of the results; in this case, it may affect the true effect of leukoreduced PRBC. Further research should also consider aspects of the study design (<a href="./references#CD009745-bbs2-0053" title="ChanAW , TetzlaffJM , GøtzschePC , AltmanDG , MannH , BerlinJA , et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ Clinical Research2013;346:e7586. [PUBMED: 23303884] ">Chan 2013</a>), such as verifying the inclusion and exclusion criteria before randomisation. Researchers should also improve the reporting of interventions and co‐interventions (<a href="./references#CD009745-bbs2-0095" title="SchulzKF , AltmanDG , MoherD , CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Medicine2010;8:18. [PUBMED: 20334633] ">Schulz 2010</a>), for example whether or not a blood transfusion includes other components or not (e.g. leukoreduced or non‐leukoreduced platelets). Moreover, further studies should address all relevant outcomes (<a href="./references#CD009745-bbs2-0060" title="GabrielSE , NormandSL . Getting the methods right‐‐the foundation of patient‐centered outcomes research. The New England Journal of Medicine2012;367(9):787‐90. [PUBMED: 22830434] ">Gabriel 2012</a>), such as death from any cause, infectious complications (e.g. risk of CMV transmission, or at least, evaluate the risk of CMV reactivation from transfused leukoreduced PRBC cells), non‐infectious complications (e.g. TRALI, NHFRT) and any other adverse events related to the PRBC transfusion. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009745-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009745-sec-0015"></div> <div class="table" id="CD009745-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Leukoreduced PRBCs versus non‐leukoreduced PRBCs for preventing adverse reaction from allogeneic blood transfusion</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Leukoreduced PRBCs versus non‐leukoreduced PRBCs for preventing adverse reaction from allogeneic blood transfusion</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients receiving RBC transfusion<br/> <b>Settings:</b> Any<br/> <b>Intervention:</b> Leukoreduced PRBCs<br/> <b>Comparison:</b> Non‐leukoreduced PRBCs </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Non‐leukoreduced packed RBCs</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Leukoreduced packed RBCs</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>TRALI</b> <br/> Follow‐up: mean 28 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.96</b> <br/> (0.67 to 1.36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1864<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>TSA yielded an inconclusive result.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>63 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>61 per 1000</b> <br/> (42 to 86) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Death due to any cause</b> <br/> Follow‐up: median 2.5 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.81</b> <br/> (0.58 to 1.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6485<br/> (9 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>TSA yielded an inconclusive<br/> result. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>93 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>76 per 1000</b> <br/> (54 to 104) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Infection from any cause</b> <br/> Follow‐up: mean 2.5 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.80</b> <br/> (0.62 to 1.03) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6709<br/> (10 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>TSA yielded an inconclusive<br/> result. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>204 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>163 per 1000</b> <br/> (127 to 210) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b> <br/> Follow‐up: mean 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.81</b> <br/> (0.64 to 1.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>634<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>TSA yielded an inconclusive<br/> result. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>387 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>314 per 1000</b> <br/> (248 to 395) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Non‐infectious complication</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>No trial assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> was the median control group risk across studies. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>TRALI:</b> Transfusion‐related acute lung injury; <b>RBC:</b> Red blood cell; <b>PRBC:</b> Packed red blood cell; <b>DARIS:</b> Diversity‐adjusted required information size. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by two due to imprecision: small sample size as compared with the calculated DARIS and the wide CI overlapping zones of no effect, as well as potential harm or benefit, or both. Few events reported.<br/> <sup>2</sup>Downgraded due to: high risk of bias (Six of nine included studies have high or unclear risk of bias. ‐1); important heterogeneity (I² statistic: 63%, ‐1); and imprecision as reflected in the wide CI and an insufficient accrued information size compared with the DARIS (‐1). </p> <p><sup>3</sup>Downgraded due to: high risk of bias (Seven of 10 included studies were at high or unclear risk of bias, ‐1); important heterogeneity (I² statistic: 84%, ‐2); and imprecision due to the CI crossing the threshold of meaningful effect and an insufficient sample size as compared with the DARIS (‐1) </p> <p><sup>4</sup>Downgraded due to: high risk of bias (All included studies evaluated were at high risk of bias, ‐1) and imprecision due to the CI crossing the threshold of meaningful effect and an insufficient sample size as compared with the DARIS (‐1). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009745-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009745-sec-0016">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009745-sec-0133">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD009745-sec-0016"></div> <section id="CD009745-sec-0017"> <h3 class="title" id="CD009745-sec-0017">Description of the condition</h3> <p>Blood transfusion is the infusion of both soluble and cell‐associated forms (red blood cells (RBCs), white blood cells (WBCs) and platelets) into a recipient (<a href="./references#CD009745-bbs2-0108" title="VamvakasEC , BlajchmanMA . Deleterious clinical effects of transfusion‐associated immunomodulation: fact or fiction?. Blood2001;97(5):1180‐95. [PUBMED: 11222359] ">Vamvakas 2001</a>). A blood transfusion is an acute intervention, implemented to solve life and health‐threatening conditions on a short‐term basis; and in general, its long‐term effects tend to be of secondary importance (<a href="./references#CD009745-bbs2-0105" title='TsaiAG , HofmannA , CabralesP , IntagliettaM . Perfusion vs. oxygen delivery in transfusion with "fresh" and "old" red blood cells: the experimental evidence. Transfusion and Apheresis Science2010;43(1):69‐78. [PUBMED: 20646963] '>Tsai 2010</a>). </p> <p>However, blood transfusion is associated with an increasing risk of infectious and non‐infectious adverse events (<a href="./references#CD009745-bbs2-0111" title="WagnerSJ . Transfusion‐transmitted bacterial infection: risks, sources and interventions. Vox Sanguinis2004;86(3):157‐63. [PUBMED: 15078249] ">Wagner 2004</a>; <a href="./references#CD009745-bbs2-0073" title="HendricksonJE , HillyerCD . Noninfectious serious hazards of transfusion. Anesthesia and Analgesia2009;108(3):759‐69. [PUBMED: 19224780] ">Hendrickson 2009</a>; <a href="./references#CD009745-bbs2-0093" title="SachsUJ . Non‐infectious serious hazards in plasma transfusion. Transfusion and Apheresis Science2010;43(3):381‐6. [PUBMED: 20934385] ">Sachs 2010</a>). The incidence of non‐infectious transfusion reactions is greater than that of infectious complications (<a href="./references#CD009745-bbs2-0081" title="LavoieJ . Blood transfusion risks and alternative strategies in pediatric patients. Paediatric Anaesthesia2011;21(1):14‐24. [PUBMED: 21155923] ">Lavoie 2011</a>). Mortality associated with non‐infectious risks is also significantly higher and accounts for 87% to 100% of fatal complications of transfusions (<a href="./references#CD009745-bbs2-0081" title="LavoieJ . Blood transfusion risks and alternative strategies in pediatric patients. Paediatric Anaesthesia2011;21(1):14‐24. [PUBMED: 21155923] ">Lavoie 2011</a>). </p> <p>The main non‐infectious adverse events to the patient are transfusion‐related acute lung injury (TRALI), which is considered the most severe non‐infectious complication (<a href="./references#CD009745-bbs2-0089" title="RenaudierP , RebiboD , WallerC , SchlangerS , Vo MaiMP , OunnougheneN , et al. Pulmonary complications of transfusion (TACO‐TRALI) [Complications pulmonaires de la transfusion (TACO–TRALI)]. Transfusion Clinique et Biologique2009;16(2):218‐32. [PUBMED: 19446484] ">Renaudier 2009</a>; <a href="./references#CD009745-bbs2-0104" title="TriulziDJ . Transfusion‐related acute lung injury: current concepts for the clinician. Anesthesia and Analgesia2009;108(3):770‐6. [PUBMED: 19224781] ">Triulzi 2009</a>; <a href="./references#CD009745-bbs2-0110" title="VamvakasEC , BlajchmanMA . Transfusion‐related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood2009;113(15):3406‐17. [PUBMED: 19188662 ] ">Vamvakas 2009</a>); non‐haemolytic febrile transfusion reaction (NHFTR) (<a href="./references#CD009745-bbs2-0079" title="KingKE , ShireyRS , ThomanSK , Bensen‐KennedyD , TanzWS , NessPM . Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. Transfusion2004;44(1):25‐9. [PUBMED: 14692963] ">King 2004</a>; <a href="./references#CD009745-bbs2-0045" title="BlajchmanMA . The clinical benefits of the leukoreduction of blood products. The Journal of Trauma2006;60(6 Suppl):S83‐90. [PUBMED: 16763486] ">Blajchman 2006</a>; <a href="./references#CD009745-bbs2-0077" title="HoffmanR , FurieB , McGlaveP , SilbersteinLE , ShattilSJ , BenzEJ , et al. Hematology: Basic Principles and Practice. 5th Edition. London: Churchill Livingstone, 2008. ">Hoffman 2008</a>) and allergic reactions (<a href="./references#CD009745-bbs2-0098" title="TenorioGC , GupteSC , MunkerR . Transfusion Medicine and Immunohematology. In: MunkerR , HillerE , GlassJ ,  PaquetteR editor(s). Modern Hematology. 2nd Edition. Totowa, NJ: Humana Press Inc, 2007:401‐32. [ISBN‐13: 978‐1‐58829‐557‐6] ">Tenorio 2007</a>).  Less frequent are transfusion‐associated graft‐versus‐host disease (TA‐GVHD) (<a href="./references#CD009745-bbs2-0056" title="DwyreDM , HollandPV . Transfusion‐associated graft‐versus‐host disease. Vox Sanguinis2008;95(2):85‐93. [PUBMED: 18544121] ">Dwyre 2008</a>; <a href="./references#CD009745-bbs2-0077" title="HoffmanR , FurieB , McGlaveP , SilbersteinLE , ShattilSJ , BenzEJ , et al. Hematology: Basic Principles and Practice. 5th Edition. London: Churchill Livingstone, 2008. ">Hoffman 2008</a>; <a href="./references#CD009745-bbs2-0092" title="RühlH , BeinG , SachsUJ . Transfusion‐associated graft‐versus‐host disease. Transfusion Medicine Reviews2009;23(1):62‐71. [PUBMED: 19056035] ">Rühl 2009</a>) and transfusion‐related with an immunomodulation effect (TRIM) (<a href="./references#CD009745-bbs2-0109" title="VamvakasEC . Deleterious clinical effects of allogenic blood tranfusion‐related immunomodulation. Facts or fiction? An update through 2005. American Journal of Clinical Pathology2006;126(Suppl 1):S71‐85. [DOI: 10.1309/9B7RWAYVVLCL58WW] ">Vamvakas 2006</a>). </p> <p>Several approaches have been considered to prevent adverse reactions related to transfusion (<a href="./references#CD009745-bbs2-0085" title="Martí‐CarvajalAJ , SolàI , GonzálezLE , Leon de GonzalezG , Rodriguez‐MalagonN . Pharmacological interventions for the prevention of allergic and febrile non‐haemolytic transfusion reactions. Cochrane Database of Systematic Reviews2010, Issue 6. [DOI: 10.1002/14651858.CD007539] ">Martí‐Carvajal 2010</a>; <a href="./references#CD009745-bbs2-0081" title="LavoieJ . Blood transfusion risks and alternative strategies in pediatric patients. Paediatric Anaesthesia2011;21(1):14‐24. [PUBMED: 21155923] ">Lavoie 2011</a>; <a href="./references#CD009745-bbs2-0083" title="LindholmPF , AnnenK , RamseyG . Approaches to minimize infection risk in blood banking and transfusion practice. Infectious Disorders Drug Targets2011;11(1):45‐56. [PUBMED: 21303341] ">Lindholm 2011</a>; <a href="./references#CD009745-bbs2-0102" title="TobianAA , SavageWJ , TischDJ , ThomanS , KingKE , NessPM . Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction. Transfusion2011;51(8):1676‐83. [PUBMED: 21214585] ">Tobian 2011</a>). Transfusion of leukocyte‐reduced RBC concentrates is one of those approaches (<a href="./references#CD009745-bbs2-0046" title="BlajchmanMA , GlynnSA , JosephsonCD , KleinmanSH , State‐of‐the Science Symposium Transfusion Medicine Committee. Clinical trial opportunities in Transfusion Medicine: proceedings of a National Heart, Lung, and Blood Institute State‐of‐the‐Science Symposium. Transfusion Medicine Reviews2010;24(4):259‐85. [PUBMED: 20851330] ">Blajchman 2010</a>; <a href="./references#CD009745-bbs2-0049" title="BlumbergN , HealJM , GettingsKF , PhippsRP , MaselD , RefaaiMA , et al. An association between decreased cardiopulmonary complications (transfusion‐related acute lung injury and transfusion‐associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion2010;50(12):2738‐44. [PUBMED: 20561296] ">Blumberg 2010</a>; <a href="./references#CD009745-bbs2-0086" title="MukagatareI , MonfortM , deMarchinJ , GerardC . The effect of leukocyte‐reduction on the transfusion reactions to red blood cells concentrates [Effet de la déleucocytation des concentrés érythrocytaires sur les réactions transfusionnelles]. Transfusion Clinique et Biologique2010;17(1):14‐9. [PUBMED: 20106700] ">Mukagatare 2010</a>). Leukocytes (WBCs) in blood components can mediate febrile transfusion reactions, stimulate human leukocyte antigen (HLA) alloimmunization in transfusion recipients, and transmit some cell‐associated pathogens such as cytomegalovirus (CMV). Therefore, it is desirable to remove WBCs from transfusable blood components (<a href="./references#CD009745-bbs2-0061" title="GalelSA , NguyenDD , FontaineMJ , GoodnoughLT , VieleMK . Transfusion Medicine. In: GreerJP , FoersterJ , RodgersGM , ParaskevasF , GladerB , ArberDA editor(s). Wintrobe's Clinical Hematology. 12th Edition. Vol. 1, Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams &amp; Wilkins, 2009:672‐721. ">Galel 2009</a>). </p> <p><a href="./appendices#CD009745-sec-0111">Appendix 1</a> shows non‐infectious transfusion reaction definitions related to WBCs. </p> </section> <section id="CD009745-sec-0018"> <h3 class="title" id="CD009745-sec-0018">Description of the intervention</h3> <p>Leukoreduction is a process in which the WBCs are intentionally reduced by almost 99.99% in RBC concentrates (<a href="./references#CD009745-bbs2-0096" title="ShapiroMJ . To filter blood or universal leukoreduction: what is the answer?. Critical Care2004;8 Suppl 2:S27‐30. [PUBMED: 15196319] ">Shapiro 2004</a>). There are many methods to conduct this approach; however, this process is currently performed using selective leukoreduction filters (<a href="./references#CD009745-bbs2-0061" title="GalelSA , NguyenDD , FontaineMJ , GoodnoughLT , VieleMK . Transfusion Medicine. In: GreerJP , FoersterJ , RodgersGM , ParaskevasF , GladerB , ArberDA editor(s). Wintrobe's Clinical Hematology. 12th Edition. Vol. 1, Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams &amp; Wilkins, 2009:672‐721. ">Galel 2009</a>). According to the U.S. Food and Drug Administration (FDA), leukocyte‐reduced RBC concentrates contain fewer than 5 × 10<sup>6</sup> WBCs/unit and at least 85% of the original RBCs (<a href="./references#CD009745-bbs2-0061" title="GalelSA , NguyenDD , FontaineMJ , GoodnoughLT , VieleMK . Transfusion Medicine. In: GreerJP , FoersterJ , RodgersGM , ParaskevasF , GladerB , ArberDA editor(s). Wintrobe's Clinical Hematology. 12th Edition. Vol. 1, Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams &amp; Wilkins, 2009:672‐721. ">Galel 2009</a>), and according to the Council of Europe &lt; 1 × 10<sup>6</sup> total WBC/unit. Usually, most RBC leukofiltration is performed by blood collection centres within the first few days after collection (<a href="./references#CD009745-bbs2-0061" title="GalelSA , NguyenDD , FontaineMJ , GoodnoughLT , VieleMK . Transfusion Medicine. In: GreerJP , FoersterJ , RodgersGM , ParaskevasF , GladerB , ArberDA editor(s). Wintrobe's Clinical Hematology. 12th Edition. Vol. 1, Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams &amp; Wilkins, 2009:672‐721. ">Galel 2009</a>). </p> <section id="CD009745-sec-0019"> <h4 class="title">Leukoreduction in trauma patients</h4> <p>Safe transfusion products are a necessity for the successful treatment of trauma patients (<a href="./references#CD009745-bbs2-0101" title="TienH , NascimentoBJr , CallumJ , RizoliS . An approach to transfusion and hemorrhage in trauma: current perspectives on restrictive transfusion strategies. Canadian Journal of Surgery2007;50(3):202‐9. [PUBMED: 17568492] ">Tien 2007</a>; <a href="./references#CD009745-bbs2-0099" title="TheusingerOM , SpahnDR , GanterMT . Transfusion in trauma: why and how should we change our current practice?. Current Opinion in Anaesthesiology2009;22(2):305‐12. [PUBMED: 19390257] ">Theusinger 2009</a>). It is unclear if leukoreduction of RBC concentrates is the best method of providing blood products for trauma patients (<a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>; <a href="./references#CD009745-bbs2-0088" title="PhelanHA , SperryJL , FrieseRS . Leukoreduction before red blood cell transfusion has no impact on mortality in trauma patients. Journal of Surgical Research2007;138(1):32‐6. [PUBMED: 17161430] ">Phelan 2007</a>; <a href="./references#CD009745-bbs2-0112" title="WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Watkins 2008</a>). Retrospective studies have shown a reduction of infectious complications in injured patients treated with leukoreduced AlloBT; this effect appears more pronounced in patients receiving massive transfusion (&gt; 6 units of PRBC) (<a href="./references#CD009745-bbs2-0059" title="FrieseRS , SperryJL , PhelanHA , GentilelloLM . The use of leukoreduced red blood cell products is associated with fewer infectious complications in trauma patients. American Journal of Surgery2008;196(1):56‐61. [PUBMED: 18513694] ">Friese 2008</a>). </p> </section> <section id="CD009745-sec-0020"> <h4 class="title">Leukoreduction in surgery</h4> <p>Several studies have focused on the advantages of leukoreduced PRBC cells for transfusion in cardiac surgery (<a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>; <a href="./references#CD009745-bbs2-0019" title="DzikWH , AndersonJK , O'NeillEM , AssmannSF , KalishLA , StowellCP . A prospective, randomized clinical trial of universal WBC reduction. Transfusion2002;42(9):1114‐22. [PUBMED: 12430666] ">Dzik 2002</a>; <a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0012" title="LangeMM , vanHiltenJA , van deWateringLM , BijnenBA , RoumenRM , PutterH , et al. Leucocyte depletion of perioperative blood transfusion does not affect long‐term survival and recurrence in patients with gastrointestinal cancer. The British Journal of Surgery2009;96(7):734‐40. [PUBMED: 19526613] vanHiltenJA , van deWateringLM , vanBockelJH , van deVeldeCJ , KievitJ , BrandR , et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ2004;328(7451):1281. [PUBMED: 15142885] ">van Hilten 2004</a>; <a href="./references#CD009745-bbs2-0016" title="ConneryCP , ToumpoulisIK , AnagnostopoulosCE , HillelZ , RahmanFG , KatritsisD , et al. Does leukofiltration reduce pulmonary infections in CABG patients? A prospective, randomized study with early results and mid‐term survival. Acta Cardiologica2005;60(3):285‐93. [PUBMED: 15999468] ">Connery 2005</a>); colorectal surgery (<a href="./references#CD009745-bbs2-0026" title="JensenLS , AndersenAJ , ChristiansenPM , HoklandP , JuhlCO , MadsenG , et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. The British Journal of Surgery1992;79(6):513‐6. [PUBMED: 1611441] JensenLS , HoklandM , NielsenHJ . A randomized controlled study of the effect of bedside leucocyte depletion on the immunosuppressive effect of whole blood transfusion in patients undergoing elective colorectal surgery. The British Journal of Surgery1996;83(7):973‐7. [PUBMED: 8813790] ">Jensen 1992</a>; <a href="./references#CD009745-bbs2-0025" title="HoubiersJG , BrandA , Van DeWateringLM , HermansJ , VerweyPJ , BijnenAB , et al. Randomised controlled trial comparing transfusion of leucocyte‐depleted or buffy‐coat‐depleted blood in surgery for colorectal cancer. Lancet1994;344(8922):573‐8. [PUBMED: 7914960] Van DeWateringLM , BrandA , HoubiersJG , Klein KranenbargWM , HermansJ , Van DeVeldeC . Perioperative blood transfusions, with or without allogeneic leucocytes, relate to survival, not to cancer recurrence. The British Journal of Surgery2001;88(2):267‐72. [PUBMED: 11167879] ">Houbiers 1994</a>; <a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a>; <a href="./references#CD009745-bbs2-0010" title="TitlestadIL , EbbesenLS , AinsworthAP , LillevangST , QvistN , GeorgsenJ . Leukocyte‐depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double‐blinded, randomized study. International Journal of Colorectal Disease2001;16(3):147‐53. [PUBMED: 11459288] ">Titlestad 2001</a>; <a href="./references#CD009745-bbs2-0019" title="DzikWH , AndersonJK , O'NeillEM , AssmannSF , KalishLA , StowellCP . A prospective, randomized clinical trial of universal WBC reduction. Transfusion2002;42(9):1114‐22. [PUBMED: 12430666] ">Dzik 2002</a>; <a href="./references#CD009745-bbs2-0034" title="SkånbergJ , LundholmK , HaglindE . Effects of blood transfusion with leucocyte depletion on length of hospital stay, respiratory assistance and survival after curative surgery for colorectal cancer. Acta Oncologica2007;46(8):1123‐30. [PUBMED: 17851860] ">Skånberg 2007</a>); gastrointestinal surgery (<a href="./references#CD009745-bbs2-0009" title="TartterPI , MohandasK , AzarP , EndresJ , KaplanJ , SpivackM . Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. American Journal of Surgery1998;176(5):462‐6. [PUBMED: 9874434] ">Tartter 1998</a>; <a href="./references#CD009745-bbs2-0019" title="DzikWH , AndersonJK , O'NeillEM , AssmannSF , KalishLA , StowellCP . A prospective, randomized clinical trial of universal WBC reduction. Transfusion2002;42(9):1114‐22. [PUBMED: 12430666] ">Dzik 2002</a>; <a href="./references#CD009745-bbs2-0012" title="LangeMM , vanHiltenJA , van deWateringLM , BijnenBA , RoumenRM , PutterH , et al. Leucocyte depletion of perioperative blood transfusion does not affect long‐term survival and recurrence in patients with gastrointestinal cancer. The British Journal of Surgery2009;96(7):734‐40. [PUBMED: 19526613] vanHiltenJA , van deWateringLM , vanBockelJH , van deVeldeCJ , KievitJ , BrandR , et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ2004;328(7451):1281. [PUBMED: 15142885] ">van Hilten 2004</a>); and renal transplantation (<a href="./references#CD009745-bbs2-0008" title="SanfilippoFP , BollingerRR , MacQueenJM , BrooksBJ , KoepkeJA . A randomized study comparing leukocyte‐depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients. Transfusion1985;25(2):116‐9. [PUBMED: 3885483] ">Sanfilippo 1985</a>; <a href="./references#CD009745-bbs2-0032" title="OpelzG , VanrenterghemY , KirsteG , GrayDW , HorsburghT , LachanceJG , et al. Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation1997;63(7):964‐7. [PUBMED: 9112348] ">Opelz 1997</a>; <a href="./references#CD009745-bbs2-0074" title="HiesseC , BussonM , BuissonC , FarahmandH , BierlingP , BenbunanM , et al. Multicenter trial of one HLA‐DR‐matched or mismatched blood transfusion prior to cadaveric renal transplantation. Kidney International2001;60(1):341‐9. [PUBMED: 11422770] ">Hiesse 2001</a>). However, some of the findings of these published trials are considered controversial. Furthermore, this approach has been used in patients with AIDS; but, is unclear if this alternative method is beneficial in this population (<a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>). </p> </section> </section> <section id="CD009745-sec-0021"> <h3 class="title" id="CD009745-sec-0021">How the intervention might work</h3> <p>Leukoreduction works through multiple mechanisms for preventing adverse reactions:</p> <p> <ol id="CD009745-list-0001"> <li> <p>To prevent TRALI: avoiding the transfer of leukocytes and reducing the cellular antibody interaction complexes that damage the endothelium of the lung (<a href="./references#CD009745-bbs2-0104" title="TriulziDJ . Transfusion‐related acute lung injury: current concepts for the clinician. Anesthesia and Analgesia2009;108(3):770‐6. [PUBMED: 19224781] ">Triulzi 2009</a>; <a href="./references#CD009745-bbs2-0094" title="SachsUJ , WaselW , BayatB , BohleRM , HattarK , BerghöferH , et al. Mechanism of transfusion‐related acute lung injury induced by HLA class II antibodies. Blood2011;117(2):669‐77. [PUBMED: 21030555] ">Sachs 2011</a>). </p> </li> <li> <p>To avoid post‐transfusion infections through reducing some cell‐associated pathogens, such as CMV (<a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0044" title="BlajchmanMA , GoldmanM , WebertKE , VamvakasEC , HannonJ , DelageG . Proceedings of a consensus conference: the screening of blood donors for variant CJD. Transfusion Medicine Reviews2004;18(2):73‐92. [PUBMED: 15067588] ">Blajchman 2004</a>; <a href="./references#CD009745-bbs2-0012" title="LangeMM , vanHiltenJA , van deWateringLM , BijnenBA , RoumenRM , PutterH , et al. Leucocyte depletion of perioperative blood transfusion does not affect long‐term survival and recurrence in patients with gastrointestinal cancer. The British Journal of Surgery2009;96(7):734‐40. [PUBMED: 19526613] vanHiltenJA , van deWateringLM , vanBockelJH , van deVeldeCJ , KievitJ , BrandR , et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ2004;328(7451):1281. [PUBMED: 15142885] ">van Hilten 2004</a>; <a href="./references#CD009745-bbs2-0016" title="ConneryCP , ToumpoulisIK , AnagnostopoulosCE , HillelZ , RahmanFG , KatritsisD , et al. Does leukofiltration reduce pulmonary infections in CABG patients? A prospective, randomized study with early results and mid‐term survival. Acta Cardiologica2005;60(3):285‐93. [PUBMED: 15999468] ">Connery 2005</a>; <a href="./references#CD009745-bbs2-0059" title="FrieseRS , SperryJL , PhelanHA , GentilelloLM . The use of leukoreduced red blood cell products is associated with fewer infectious complications in trauma patients. American Journal of Surgery2008;196(1):56‐61. [PUBMED: 18513694] ">Friese 2008</a>). </p> </li> <li> <p>To prevent immunomodulation: donor WBCs may suppress the recipient's immune system by interacting with it, producing susceptibility to many pathological conditions including cancer recurrence and other malignancies (<a href="./references#CD009745-bbs2-0043" title="BlajchmanMA . Immunomodulation and blood transfusion. American Journal of Therapeutics2002;9(5):389‐95. [PUBMED: 12237730] ">Blajchman 2002</a>; <a href="./references#CD009745-bbs2-0055" title="DellingerEP , AnayaDA . Infectious and immunologic consequences of blood transfusion. Critical Care2004;8(Suppl 2):S18‐23. [PUBMED: 15196317] ">Dellinger 2004</a>; <a href="./references#CD009745-bbs2-0058" title="FlohéS , KobbeP , Nast‐KolbD . Immunological reactions secondary to blood transfusion. Injury2007;38(12):1405‐8. [PUBMED: 18048035] ">Flohé 2007</a>). </p> </li> </ol> </p> </section> <section id="CD009745-sec-0022"> <h3 class="title" id="CD009745-sec-0022">Why it is important to do this review</h3> <p>This Cochrane review is important for the following reasons:</p> <p>Firstly, leukoreduction is expensive. About EUR 29 million/year are spent on implementing leukoreduction (<a href="./references#CD009745-bbs2-0041" title="AguadoM , VillegasR , MárquezS , CorbachoB , NavarroJ . Universal leukorreduction. A systematic review of the literature and an economic assessment. Executive summary [Leucorreducción universal de productos sanguíneos. Revisión Sistemática de la Literatura y Evaluación Económica.]. Agencia de Evaluación de Tecnologías Sanitarias de Andalucía2007:1‐95. ">AETSA 2007</a>). Other studies reported costs ranging from CAD $26 million to 46 million annually (<a href="./references#CD009745-bbs2-0052" title="GibisB , BaladiJF . Leukoreduction: the techniques used, their effectiveness and costs. Canadian Coordinating Office for Health Technology Assessmnet (CCOHTA). https://www.cadth.ca/sites/default/files/pdf/leukoreduct_tr_e.pdf (accessed 15 August 2015). [IBSN 1‐895561‐60‐4] ">CCOHTA 1998</a>). One study estimated the total cost of implementing leukoreduction was about USD 600 million dollars per year in USA (<a href="./references#CD009745-bbs2-0096" title="ShapiroMJ . To filter blood or universal leukoreduction: what is the answer?. Critical Care2004;8 Suppl 2:S27‐30. [PUBMED: 15196319] ">Shapiro 2004</a>). It has also been reported that leukoreduction results in an increase of approximately USD 30/unit of blood product (<a href="./references#CD009745-bbs2-0088" title="PhelanHA , SperryJL , FrieseRS . Leukoreduction before red blood cell transfusion has no impact on mortality in trauma patients. Journal of Surgical Research2007;138(1):32‐6. [PUBMED: 17161430] ">Phelan 2007</a>). More recently, <a href="./references#CD009745-bbs2-0106" title="TsantesAE , KyriakouE , NikolopoulosGK , StylosD , SidhomM , BonovasS , et al. Cost‐effectiveness of leucoreduction for prevention of febrile non‐haemolytic transfusion reactions. Blood Transfusion2014;12(2):232‐7. [PUBMED: 24931843] ">Tsantes 2014</a> reported an incremental cost‐effectiveness ratio (ICER) of EUR 6916 to prevent one case of febrile non‐haemolytic transfusion reactions (FNHTR). Secondly, the potential role of leukoreduction for decreasing mortality and infection is controversial (<a href="./references#CD009745-bbs2-0041" title="AguadoM , VillegasR , MárquezS , CorbachoB , NavarroJ . Universal leukorreduction. A systematic review of the literature and an economic assessment. Executive summary [Leucorreducción universal de productos sanguíneos. Revisión Sistemática de la Literatura y Evaluación Económica.]. Agencia de Evaluación de Tecnologías Sanitarias de Andalucía2007:1‐95. ">AETSA 2007</a>; <a href="./references#CD009745-bbs2-0086" title="MukagatareI , MonfortM , deMarchinJ , GerardC . The effect of leukocyte‐reduction on the transfusion reactions to red blood cells concentrates [Effet de la déleucocytation des concentrés érythrocytaires sur les réactions transfusionnelles]. Transfusion Clinique et Biologique2010;17(1):14‐9. [PUBMED: 20106700] ">Mukagatare 2010</a>). Thirdly<i>,</i> several studies and meta‐analyses did not report conclusive results about leukoreduction, and showed methodological inconsistencies (<a href="./references#CD009745-bbs2-0107" title="VamvakasEC , CarvenJH , HibberdPL . Blood transfusion and infection after colorectal cancer surgery. Transfusion1996;36(11‐12):1000‐8. [PUBMED: 8937412] ">Vamvakas 1996</a>; <a href="./references#CD009745-bbs2-0047" title="BlumbergN . Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta‐analysis of unconfounded studies. The British Journal of Surgery1998;85(8):1163‐4. [PUBMED: 9718033] ">Blumberg 1998</a>; <a href="./references#CD009745-bbs2-0078" title="JensenLS . Benefits of leukocyte‐reduced blood transfusions in surgical patients. Current Opinion in Hematology1998;5(6):376‐80. [PUBMED: 9814642] ">Jensen 1998</a>; <a href="./references#CD009745-bbs2-0057" title="FergussonD , KhannaMP , TinmouthA , HébertPC . Transfusion of leukoreduced red blood cells may decrease postoperative infections: two meta‐analyses of randomized controlled trials. Canadian Journal of Anaesthesia (Journal Canadien d'Anesthésie)2004;51(5):417‐24. [PUBMED: 15128625] ">Fergusson 2004</a>; <a href="./references#CD009745-bbs2-0048" title="BlumbergN , ZhaoH , WangH , MessingS , HealJM , LymanGH . The intention‐to‐treat principle in clinical trials and meta‐analyses of leukoreduced blood transfusions in surgical patients. Transfusion2007;47(4):573‐81. [PUBMED: 17381614] ">Blumberg 2007</a>; <a href="./references#CD009745-bbs2-0036" title="VamvakasEC . White‐blood‐cell‐containing allogeneic blood transfusion and postoperative infection or mortality: an updated meta‐analysis. Vox Sanguinis2007;92(3):224‐32. [PUBMED: 17348871] ">Vamvakas 2007</a>). Therefore, it is important to conduct this Cochrane review to determine the potential benefits of leukoreduction procedure in patients requiring RBC concentrates, focused on the prevention of adverse reaction. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009745-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009745-sec-0023">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009745-sec-0140">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009745-sec-0023"></div> <p>To determine the clinical effectiveness of leukoreduction of packed red blood cells for preventing adverse reactions following allogeneic blood transfusion. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009745-sec-0024" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009745-sec-0024">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009745-sec-0141">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009745-sec-0024"></div> <section id="CD009745-sec-0025"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009745-sec-0026"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs).</p> </section> <section id="CD009745-sec-0027"> <h4 class="title">Types of participants</h4> <p>Patients requiring allogeneic packed RBC (PRBC) transfusion. Patients could be of any age. </p> </section> <section id="CD009745-sec-0028"> <h4 class="title">Types of interventions</h4> <section id="CD009745-sec-0029"> <h5 class="title">Intervention</h5> <p> <ul id="CD009745-list-0002"> <li> <p>Leukoreduced PRBCs.</p> </li> </ul> </p> </section> <section id="CD009745-sec-0030"> <h5 class="title">Comparison</h5> <p> <ul id="CD009745-list-0003"> <li> <p>Non‐leukoreduced PRBCs.</p> </li> </ul> </p> <p>We applied no limitations to the leukoreduction procedures used.</p> </section> </section> <section id="CD009745-sec-0031"> <h4 class="title">Types of outcome measures</h4> <section id="CD009745-sec-0032"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD009745-list-0004"> <li> <p>Incidence of TRALI.</p> </li> </ol> </p> </section> <section id="CD009745-sec-0033"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD009745-list-0005"> <li> <p>Death due to any cause.</p> </li> <li> <p>Infection from any cause (number of patients out of the total randomised).</p> </li> <li> <p>Non‐infectious complications (<a href="./appendices#CD009745-sec-0111">Appendix 1</a>). </p> </li> <li> <p>Any other adverse event: “any untoward medical occurrence that may present during treatment with a pharmaceutical product but which does not necessarily have a causal relationship with this treatment” (<a href="./references#CD009745-bbs2-0087" title="NebekerJR , BarachP , SamoreMH . Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Annals of Internal Medicine2004;140(10):795‐801. [PUBMED: 15148066] ">Nebeker 2004</a>). </p> </li> </ol> </p> <p>We took the information size for the primary outcome of this Cochrane review from the relative risk reported in <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>. This study included trauma patients. A total sample size of 8781 participants was defined to assess a relative risk reduction on TRALI events of 25%, from a baseline incidence in the control of 6.31% (alpha level of 5% and power of 90%). </p> </section> </section> </section> <section id="CD009745-sec-0034"> <h3 class="title">Search methods for identification of studies</h3> <p>In order to reduce publication and retrieval bias we did not restrict our search by language, date or publication status<b>.</b> </p> <section id="CD009745-sec-0035"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Injuries Group Trials Search Co‐ordinator searched the following:</p> <p> <ol id="CD009745-list-0006"> <li> <p>Cochrane Injuries Group Specialised Register (10/11/2015)</p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL, the Cochrane Library) (issue 10 of 12, 2015) </p> </li> <li> <p>MEDLINE (OvidSP) (1950 to November week 1, 2015)</p> </li> <li> <p>Embase + Embase Classic (OvidSP) (1947 to 10/11/2015)</p> </li> <li> <p>LILACS (BIREME) (1982 to 10/11/2015)</p> </li> <li> <p>CINAHL Plus (EBSCO) (1937 to 10/11/2015)</p> </li> <li> <p>Clinicaltrials.gov (www.clinicaltrials.gov) (10/1/2015)</p> </li> <li> <p>WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">http://apps.who.int/trialsearch/</a>) (10/11/2015) </p> </li> </ol> </p> <p>We have reported the search strategies in <a href="./appendices#CD009745-sec-0112">Appendix 2</a>. We adapted the MEDLINE search strategy as necessary for the other databases. To the MEDLINE search strategy we added the Cochrane Highly Sensitive Search Strategy for identifying RCTs. To the EMBASE strategy we added the terms of the search strategy and study design terms as used by the UK Cochrane Centre (<a href="./references#CD009745-bbs2-0082" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Lefebvre 2011</a>). </p> </section> <section id="CD009745-sec-0036"> <h4 class="title">Searching other resources</h4> <p>We also searched the following websites (25 November 2014):</p> <p> <ol id="CD009745-list-0007"> <li> <p>US FDA (<a href="http://www.fda.gov" target="_blank">http://www.fda.gov</a>). </p> </li> <li> <p>European Medicines Agency (<a href="http://www.emea.europa.eu" target="_blank">http://www.emea.europa.eu</a>). </p> </li> <li> <p>Scirus (<a href="http://www.scirus.com" target="_blank">www.scirus.com</a>). </p> </li> <li> <p>American Association of Blood Banks (AABB) (<a href="http://www.aabb.org" target="_blank">http://www.aabb.org</a>). </p> </li> <li> <p>Transfusion Evidence Library (<a href="http://transfusionguidelines.org" target="_blank">http://transfusionguidelines.org</a>). </p> </li> </ol> </p> <p>In addition, we checked the reference lists of all relevant trials and reviews identified.</p> </section> </section> <section id="CD009745-sec-0037"> <h3 class="title" id="CD009745-sec-0037">Data collection and analysis</h3> <p>We summarised data according to standard Cochrane methodologies, including the <i>Cochrane Handbook of Systematic Reviews for Interventions</i> (<a href="./references#CD009745-bbs2-0076" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0[updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) and the Methodological Expectations for Cochrane Intervention Reviews (MECIR) (<a href="./references#CD009745-bbs2-0054" title="ChandlerJ , ChurchillR , HigginsJ , LassersonT , ToveyD . Methodological standards for the conduct of new Cochrane Intervention Reviews. Version 2.3. 02 December 2013. http://editorial‐unit.cochrane.org/sites/editorial‐unit.cochrane.org/files/uploads/MECIR_conduct_standards%202.3%2002122013_0.pdf (accessed 20 September 2014). ">Chandler 2013</a>). </p> <section id="CD009745-sec-0038"> <h4 class="title">Selection of studies</h4> <p>Two review authors, Daniel Simancas‐Racines (DSR) and Ingrid Arévalo‐Rodriguez (IAR), independently assessed for inclusion all the potential studies identified from the literature searches. We consulted a third review author, Arturo Martí‐Carvajal (AMC) for any disagreements, which were resolved through discussion and consensus. </p> </section> <section id="CD009745-sec-0039"> <h4 class="title">Data extraction and management</h4> <p>Two review authors, DSR and IAR, independently extracted data from the included trials. We consulted AMC and Dimelza Osorio (DO) in the event of any disagreements, which we resolved through discussion and consensus. Data were recorded for: eligibility criteria, demographics (age, gender and country), type of surgery, setting of the patients (i.e. cardiac surgery, intensive care unit (ICU)) outcomes. DSR recorded the data into a database. IAR and DO checked the data entered. </p> <p>We contacted the trial author when a full‐text article was unavailable (see <a href="./appendices#CD009745-sec-0121">Appendix 3</a> for details). </p> </section> <section id="CD009745-sec-0040"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors, DSR and IAR, independently assessed the quality of each trial using a simple form following the domain‐based evaluation as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009745-bbs2-0076" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0[updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We compared the assessments and discussed any discrepancies between the review authors. We consulted a third review author (AMC) to resolve any disagreement and to reach consensus. </p> <p>For each included trial, we assessed risk of bias (as low, high or unclear) for each of the following domains: </p> <p> <ul id="CD009745-list-0008"> <li> <p>Generation of random sequence (selection bias).</p> </li> <li> <p>Concealment of treatment allocation (selection bias).</p> </li> <li> <p>Blinding of participants and personnel (person delivering treatment) to treatment allocation (performance bias). </p> </li> <li> <p>Blinding of outcome assessors to treatment allocation (detection bias).</p> </li> <li> <p>Completeness of the outcome data (including checks for possible attrition bias through withdrawals, loss to follow‐up and protocol violations). For the incomplete outcome data domain, we considered as a high risk of bias RCTs that losses participants after transfusion intervention. Additionally, we considered high risk of bias (design bias) as those studies in which the patients were not transfused because inconsistency to determine inclusion criteria adequately or when a premature randomisation was done. </p> </li> <li> <p>Selective reporting of outcomes (reporting bias).</p> </li> <li> <p>Other sources of bias (other bias).</p> </li> </ul> </p> </section> <section id="CD009745-sec-0041"> <h4 class="title">Measures of treatment effect</h4> <p>All outcomes in this Cochrane review were binary outcomes. We calculated the treatment effect with risk ratios (RRs) with 95% confidence intervals (CI). </p> </section> <section id="CD009745-sec-0042"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the patient. We collected and analysed a single measurement for each outcome from each patient. </p> </section> <section id="CD009745-sec-0043"> <h4 class="title">Dealing with missing data</h4> <p>We assessed the percentages of the overall dropouts for each included trial and per each randomisation arm, and we evaluated whether an intention‐to‐treat (ITT) analysis had been performed or could be performed with the available published information. We defined these dropouts as the percentage of lost patients who received an effective transfusion, over the total of transfused patients reported for each arm of the included studies. </p> </section> <section id="CD009745-sec-0044"> <h4 class="title">Assessment of heterogeneity</h4> <p>We quantified statistical heterogeneity using the I² statistic. The I² statistic describes the percentage of total variation across trials that is due to heterogeneity rather than sampling error (<a href="./references#CD009745-bbs2-0075" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. [PUBMED: 12958120] ">Higgins 2003</a>). We considered I² statistic between 50% and 74% as a moderate statistical heterogeneity, whereas a value of ≥ 75% represents high heterogeneity. We explored heterogeneity using a sensitivity analysis. </p> </section> <section id="CD009745-sec-0045"> <h4 class="title">Assessment of reporting biases</h4> <p>We created a funnel plot to assess reporting bias for each outcome (<a href="./references#CD009745-bbs2-0097" title="SterneJAC , EggerM , MoherD (editors) . Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Sterne 2011</a>) where there were data from at least 10 trials (<a href="./references#CD009745-bbs2-0076" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0[updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD009745-sec-0046"> <h4 class="title">Data synthesis</h4> <p>We summarized sufficiently comparable trials using the random‐effects model to accommodate the high heterogeneity, and used a fixed‐effect model for the sensitivity analysis. We carried out the main analysis based on the number of randomised participants, using an ITT analysis. All the analyses were carried out using <a href="./references#CD009745-bbs2-0090" title="The Cochrane Collaboration, The Nordic Cochrane Centre. Review Manager (RevMan). Version 5.3. Copenhagen: The Cochrane Collaboration, The Nordic Cochrane Centre, 2014. ">RevMan 2014</a>. </p> </section> <section id="CD009745-sec-0047"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>No data were available to perform the following subgroup analyses for the primary outcome (incidence of TRALI): </p> <p> <ol id="CD009745-list-0009"> <li> <p>By type of post‐transfusion complication.</p> </li> <li> <p>By technique or type of material used.</p> </li> <li> <p>Immunosuppressed patient versus non‐immunosuppressed patient.</p> </li> <li> <p>Massive transfusion (&gt; 6 units PRBCs) versus less.</p> </li> </ol> </p> </section> <section id="CD009745-sec-0048"> <h4 class="title">Sensitivity analysis</h4> <p>We performed the following sensitivity analysis for the primary outcome:</p> <p> <ol id="CD009745-list-0010"> <li> <p>To assess the robustness of estimates, we used both fixed‐effect and random‐effects models for all outcomes and compared results. </p> </li> <li> <p>We conducted a sensitivity analysis comparing trials with low risk of bias, with those at unclear or high risk of bias, according to attrition bias (<a href="./references#CD009745-bbs2-0076" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0[updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </li> <li> <p>We also conducted a sensitivity analysis based on transfused patients to explore the high heterogeneity. </p> </li> </ol> </p> <section id="CD009745-sec-0049"> <h5 class="title">Trial sequential analysis</h5> <p>We carried out a trial sequential analysis (TSA) for every dichotomous outcome evaluated in this systematic review: TRALI, death from any cause, infection from any cause, and adverse events/fever. </p> <p>TSA is a type of statistical power analysis that can be used to further investigate the relevance of results ("strength of evidence") yielded by a meta‐analysis (<a href="./references#CD009745-bbs2-0113" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology2008;61(1):64‐75. [PUBMED: 18083463] ">Wetterslev 2008</a>). It is the counterpart of a sample size calculation as part of a conventional study design. TSA allows researchers to differentiate between "spurious" significant findings caused by random error in a data‐set with only small numbers of participants and trials and a "truly" significant result with sufficient statistical power. Thereby, TSA also accounts for repeated significance testing. The optimal information size and O'Brien‐Fleming alpha‐spending boundaries indicating the "real" significance threshold are constructed by providing the numbers for alpha level, power, control group risk and inter‐study heterogeneity (<a href="./references#CD009745-bbs2-0100" title="ThorlundK , EngstrømJ , WetterslevJ , BrokJ , ImbergerG , GluudC . User manual for trial sequential analysis (TSA). Version available from www.ctu.dk/tsa. Copenhagen, Denmark: Copenhagen Trial Unit: Centre for Clinical Intervention Research, 2011. ">Thorlund 2011</a>). TSA can be performed only if the information size (number of participants) is large enough as compared with the optimal information size, and only if the outcome is dichotomous. Further details can be found in the "User Manual for Trial Sequential Analysis (TSA)", provided by the Centre for Clinical Intervention Research of the Copenhagen Trial Unit (<a href="./references#CD009745-bbs2-0100" title="ThorlundK , EngstrømJ , WetterslevJ , BrokJ , ImbergerG , GluudC . User manual for trial sequential analysis (TSA). Version available from www.ctu.dk/tsa. Copenhagen, Denmark: Copenhagen Trial Unit: Centre for Clinical Intervention Research, 2011. ">Thorlund 2011</a>). </p> </section> <section id="CD009745-sec-0050"> <h5 class="title">'Summary of findings' tables</h5> <p>We used the GRADE approach (<a href="./references#CD009745-bbs2-0065" title="GuyattGH , OxmanAD , KunzR , BrozekJ , Alonso‐CoelloP , RindD , et al. GRADE guidelines 6. Rating the quality of evidence‐‐imprecision. Journal of Clinical Epidemiology2011;64(12):1283‐93. [PUBMED: 21839614] ">Guyatt 2011b</a>) to assess the overall quality of evidence. The GRADE approach appraises the quality of a body of evidence based on the extent to which one can be confident that an estimate of effect or association reflects the item being assessed. The quality of a body of evidence considers within‐study risk of bias (methodological quality), the directness of the evidence, heterogeneity of the data, precision of effect estimates and risk of publication bias (<a href="./references#CD009745-bbs2-0042" title="BalshemH , HelfandM , SchünemannHJ , OxmanAD , KunzR , BrozekJ , et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology2011;64(4):401‐6. [PUBMED: 21208779] ">Balshem 2011</a>; <a href="./references#CD009745-bbs2-0050" title="BrozekJL , AklEA , CompalatiE , KreisJ , TerraccianoL , FiocchiA , et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations. Allergy2011;66(5):588‐95. [PUBMED: 21241318] ">Brozek 2011</a>; <a href="./references#CD009745-bbs2-0064" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction‐GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383‐94. [PUBMED: 21195583] ">Guyatt 2011a</a>; <a href="./references#CD009745-bbs2-0066" title="GuyattGH , OxmanAD , KunzR , AtkinsD , BrozekJ , VistG , et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. Journal of Clinical Epidemiology2011;64(4):395‐400. [PUBMED: 21194891] ">Guyatt 2011c</a>; <a href="./references#CD009745-bbs2-0067" title="GuyattGH , OxmanAD , KunzR , WoodcockJ , BrozekJ , HelfandM , et al. GRADE guidelines: 7. Rating the quality of evidence‐‐inconsistency. Journal of Clinical Epidemiology2011;64(12):1294‐302. [PUBMED: 21803546] ">Guyatt 2011d</a>; <a href="./references#CD009745-bbs2-0068" title="GuyattGH , OxmanAD , KunzR , WoodcockJ , BrozekJ , HelfandM , et al. GRADE guidelines: 8. Rating the quality of evidence‐‐indirectness. Journal of Clinical Epidemiology2011;64(12):1303‐10. [PUBMED: 21802903] ">Guyatt 2011e</a>; <a href="./references#CD009745-bbs2-0069" title="GuyattGH , OxmanAD , MontoriV , VistG , KunzR , BrozekJ , et al. GRADE guidelines: 5. Rating the quality of evidence‐‐publication bias. Journal of Clinical Epidemiology2011;64(12):1277‐82. [PUBMED: 21802904] ">Guyatt 2011f</a>; <a href="./references#CD009745-bbs2-0070" title="GuyattGH , OxmanAD , VistG , KunzR , BrozekJ , Alonso‐CoelloP , et al. GRADE guidelines: 4. Rating the quality of evidence‐‐study limitations (risk of bias). Journal of Clinical Epidemiology2011;64(4):407‐15. [PUBMED: 21247734] ">Guyatt 2011g</a>; <a href="./references#CD009745-bbs2-0071" title="GuyattGH , OxmanAD , SultanS , GlasziouP , AklEA , Alonso‐CoelloP , et al. GRADE guidelines: 9. Rating up the quality of evidence. Journal of Clinical Epidemiology2011;64(12):1311‐6. [PUBMED: 21802902] ">Guyatt 2011h</a>). We created a ‘Summary of Findings’ table using <a href="./references#CD009745-bbs2-0063" title="Evidence Prime, Inc. GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University. Evidence Prime, Inc, 2015. ">GRADEpro GDT</a> Guideline Development Tool (<a href="http://www.gradepro.org" target="_blank">www.gradepro.org</a>). We have presented the body of evidence in <a href="./full#CD009745-tbl-0001">summary of findings Table for the main comparison</a>. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009745-sec-0051" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009745-sec-0051"></div> <section id="CD009745-sec-0052"> <h3 class="title">Description of studies</h3> <p>See the <a href="#CD009745-sec-0054">Included studies</a> section. </p> <section id="CD009745-sec-0053"> <h4 class="title">Results of the search</h4> <p>We identified 6244 references. Thirteen RCTs met our inclusion criteria (<a href="./references#CD009745-bbs2-0008" title="SanfilippoFP , BollingerRR , MacQueenJM , BrooksBJ , KoepkeJA . A randomized study comparing leukocyte‐depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients. Transfusion1985;25(2):116‐9. [PUBMED: 3885483] ">Sanfilippo 1985</a>; <a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a>; <a href="./references#CD009745-bbs2-0009" title="TartterPI , MohandasK , AzarP , EndresJ , KaplanJ , SpivackM . Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. American Journal of Surgery1998;176(5):462‐6. [PUBMED: 9874434] ">Tartter 1998</a>; <a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>; <a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>; <a href="./references#CD009745-bbs2-0010" title="TitlestadIL , EbbesenLS , AinsworthAP , LillevangST , QvistN , GeorgsenJ . Leukocyte‐depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double‐blinded, randomized study. International Journal of Colorectal Disease2001;16(3):147‐53. [PUBMED: 11459288] ">Titlestad 2001</a>; <a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0012" title="LangeMM , vanHiltenJA , van deWateringLM , BijnenBA , RoumenRM , PutterH , et al. Leucocyte depletion of perioperative blood transfusion does not affect long‐term survival and recurrence in patients with gastrointestinal cancer. The British Journal of Surgery2009;96(7):734‐40. [PUBMED: 19526613] vanHiltenJA , van deWateringLM , vanBockelJH , van deVeldeCJ , KievitJ , BrandR , et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ2004;328(7451):1281. [PUBMED: 15142885] ">van Hilten 2004</a>; <a href="./references#CD009745-bbs2-0002" title="BoshkovLK , ChienG , VanWinkleD , FurnaryAP , WuY , GrunkemeirerGI , et al. Prestorage leukoreduction of transfused packed red cells is associated with significant ongoing 1‐12 month survival benefit cardiac surgery patients. Blood2006;108:578. ">Boshkov 2006</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>; <a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a>; <a href="./references#CD009745-bbs2-0004" title="DonatiA , DamianiE , LuchettiM , DomiziR , ScorcellaC , CarsettiA , et al. Microcirculatory effects of the transfusion of leukodepleted or non‐leukodepleted red blood cells in patients with sepsis: a pilot study. Critical Care2014;18(1):R33. [PUBMED: 24528648] ">Donati 2014</a>). See <a href="#CD009745-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD009745-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD009745-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>We did not find any ongoing trials. Three studies were classified as awaiting assessment (<a href="./references#CD009745-bbs2-0040" title="ZhaoS , ChenX , HuJ , LiR . Clinical assessment of preventing febrile nonhemolytic transfusion reaction by leukocyte‐depleted blood transfusion. Zhongguo Shi Yan Xue Ye Xue Za Zhi [Journal of Experimental Hematology]2002;10(6):568‐70. [PUBMED: 12513724 ] ">Zhao 2004</a>; <a href="./references#CD009745-bbs2-0038" title="Immunomodulation Following Transfusion. https://clinicaltrials.gov/ct2/show/NCT00810810. ">NCT00810810</a>; <a href="./references#CD009745-bbs2-0039" title="WaghmareN , DesaiN , KarnadD . Open Labeled, Randomized, Controlled Trial Comparing Leukodepleted (Filtered) Blood Transfusion and Non‐Leukodepleted (Unfiltered) Blood Transfusion in Cases of Severe Falciparum Malaria. Chest. Glenview (IL): Proceedings of the CHEST 2012 Annual Meeting, Atlanta (GA), October 2012; Vol. 142:Meeting Abstracts: 232A. ">Waghmare 2012</a>). There is insufficient information available about these studies to enable us to decide whether or not they should be included in the review. See <a href="./references#CD009745-sec-0132" title="">Characteristics of studies awaiting classification</a>. </p> </section> <section id="CD009745-sec-0054"> <h4 class="title">Included studies</h4> <section id="CD009745-sec-0055"> <h5 class="title">Methodology characteristics</h5> <p>Trials were published between 1985 and 2014. They were conducted in various countries: five in the USA (<a href="./references#CD009745-bbs2-0008" title="SanfilippoFP , BollingerRR , MacQueenJM , BrooksBJ , KoepkeJA . A randomized study comparing leukocyte‐depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients. Transfusion1985;25(2):116‐9. [PUBMED: 3885483] ">Sanfilippo 1985</a>; <a href="./references#CD009745-bbs2-0009" title="TartterPI , MohandasK , AzarP , EndresJ , KaplanJ , SpivackM . Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. American Journal of Surgery1998;176(5):462‐6. [PUBMED: 9874434] ">Tartter 1998</a>; <a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>; <a href="./references#CD009745-bbs2-0002" title="BoshkovLK , ChienG , VanWinkleD , FurnaryAP , WuY , GrunkemeirerGI , et al. Prestorage leukoreduction of transfused packed red cells is associated with significant ongoing 1‐12 month survival benefit cardiac surgery patients. Blood2006;108:578. ">Boshkov 2006</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>), three in the Netherlands (<a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0012" title="LangeMM , vanHiltenJA , van deWateringLM , BijnenBA , RoumenRM , PutterH , et al. Leucocyte depletion of perioperative blood transfusion does not affect long‐term survival and recurrence in patients with gastrointestinal cancer. The British Journal of Surgery2009;96(7):734‐40. [PUBMED: 19526613] vanHiltenJA , van deWateringLM , vanBockelJH , van deVeldeCJ , KievitJ , BrandR , et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ2004;328(7451):1281. [PUBMED: 15142885] ">van Hilten 2004</a>), two in Denmark (<a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a>; <a href="./references#CD009745-bbs2-0010" title="TitlestadIL , EbbesenLS , AinsworthAP , LillevangST , QvistN , GeorgsenJ . Leukocyte‐depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double‐blinded, randomized study. International Journal of Colorectal Disease2001;16(3):147‐53. [PUBMED: 11459288] ">Titlestad 2001</a>), one in France (<a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a>), one in the UK (<a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>) and one in Italy (<a href="./references#CD009745-bbs2-0004" title="DonatiA , DamianiE , LuchettiM , DomiziR , ScorcellaC , CarsettiA , et al. Microcirculatory effects of the transfusion of leukodepleted or non‐leukodepleted red blood cells in patients with sepsis: a pilot study. Critical Care2014;18(1):R33. [PUBMED: 24528648] ">Donati 2014</a>). </p> <p>All trials had a parallel study design; 11 comparing two groups and two trials comparing three groups (<a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>; <a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>). The number of trial participants ranged from 20 (<a href="./references#CD009745-bbs2-0004" title="DonatiA , DamianiE , LuchettiM , DomiziR , ScorcellaC , CarsettiA , et al. Microcirculatory effects of the transfusion of leukodepleted or non‐leukodepleted red blood cells in patients with sepsis: a pilot study. Critical Care2014;18(1):R33. [PUBMED: 24528648] ">Donati 2014</a>) to 1864 (<a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>), with a median of 531 participants. </p> <p>In three trials participants were monitored for one month or less (<a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>; <a href="./references#CD009745-bbs2-0004" title="DonatiA , DamianiE , LuchettiM , DomiziR , ScorcellaC , CarsettiA , et al. Microcirculatory effects of the transfusion of leukodepleted or non‐leukodepleted red blood cells in patients with sepsis: a pilot study. Critical Care2014;18(1):R33. [PUBMED: 24528648] ">Donati 2014</a>). In 10 trials participants were monitored for between two and 15 months. In 11 trials there was an a priori sample size estimation, and one trial did not report how the sample size was derived (<a href="./references#CD009745-bbs2-0008" title="SanfilippoFP , BollingerRR , MacQueenJM , BrooksBJ , KoepkeJA . A randomized study comparing leukocyte‐depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients. Transfusion1985;25(2):116‐9. [PUBMED: 3885483] ">Sanfilippo 1985</a>). In one trial the data used were taken from the report's abstract, and there was no information about the sample size calculation (<a href="./references#CD009745-bbs2-0002" title="BoshkovLK , ChienG , VanWinkleD , FurnaryAP , WuY , GrunkemeirerGI , et al. Prestorage leukoreduction of transfused packed red cells is associated with significant ongoing 1‐12 month survival benefit cardiac surgery patients. Blood2006;108:578. ">Boshkov 2006</a>). All trials used patients as the randomisation unit and unit of analysis. All trials reported inclusion criteria. Exclusion criteria were not reported in the <a href="./references#CD009745-bbs2-0002" title="BoshkovLK , ChienG , VanWinkleD , FurnaryAP , WuY , GrunkemeirerGI , et al. Prestorage leukoreduction of transfused packed red cells is associated with significant ongoing 1‐12 month survival benefit cardiac surgery patients. Blood2006;108:578. ">Boshkov 2006</a> study abstract. </p> </section> <section id="CD009745-sec-0056"> <h5 class="title">Patient characteristics</h5> <p>All 13 included trials were conducted in adults, but two trials also included patients under 18 years of age: <a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a> (≥ 14 years) and <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a> (≥ 17 years). Twelve trials reported the gender of the participants; almost 60% of the included participants were men. Five trials involved cardiac surgery patients (<a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>; <a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0012" title="LangeMM , vanHiltenJA , van deWateringLM , BijnenBA , RoumenRM , PutterH , et al. Leucocyte depletion of perioperative blood transfusion does not affect long‐term survival and recurrence in patients with gastrointestinal cancer. The British Journal of Surgery2009;96(7):734‐40. [PUBMED: 19526613] vanHiltenJA , van deWateringLM , vanBockelJH , van deVeldeCJ , KievitJ , BrandR , et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ2004;328(7451):1281. [PUBMED: 15142885] ">van Hilten 2004</a>; <a href="./references#CD009745-bbs2-0002" title="BoshkovLK , ChienG , VanWinkleD , FurnaryAP , WuY , GrunkemeirerGI , et al. Prestorage leukoreduction of transfused packed red cells is associated with significant ongoing 1‐12 month survival benefit cardiac surgery patients. Blood2006;108:578. ">Boshkov 2006</a>), four trials involved gastro‐oncology surgery patients (<a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a>; <a href="./references#CD009745-bbs2-0010" title="TitlestadIL , EbbesenLS , AinsworthAP , LillevangST , QvistN , GeorgsenJ . Leukocyte‐depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double‐blinded, randomized study. International Journal of Colorectal Disease2001;16(3):147‐53. [PUBMED: 11459288] ">Titlestad 2001</a>; <a href="./references#CD009745-bbs2-0012" title="LangeMM , vanHiltenJA , van deWateringLM , BijnenBA , RoumenRM , PutterH , et al. Leucocyte depletion of perioperative blood transfusion does not affect long‐term survival and recurrence in patients with gastrointestinal cancer. The British Journal of Surgery2009;96(7):734‐40. [PUBMED: 19526613] vanHiltenJA , van deWateringLM , vanBockelJH , van deVeldeCJ , KievitJ , BrandR , et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ2004;328(7451):1281. [PUBMED: 15142885] ">van Hilten 2004</a>; <a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a>), one trial involved non‐surgical oncology patients (<a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a>), one trial involved trauma patients (<a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>), one trial included HIV infected patients (<a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>) and one trial involved patients with sepsis, severe sepsis or septic shock requiring ICU care (<a href="./references#CD009745-bbs2-0004" title="DonatiA , DamianiE , LuchettiM , DomiziR , ScorcellaC , CarsettiA , et al. Microcirculatory effects of the transfusion of leukodepleted or non‐leukodepleted red blood cells in patients with sepsis: a pilot study. Critical Care2014;18(1):R33. [PUBMED: 24528648] ">Donati 2014</a>). </p> </section> <section id="CD009745-sec-0057"> <h5 class="title">Interventions</h5> <section id="CD009745-sec-0058"> <h6 class="title">Leukoreduction definition</h6> <p>The extent of leukoreduction differed across the studies: two studies obtained 0.1 to 0.3 × 10<sup>6</sup> per unit (<a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0010" title="TitlestadIL , EbbesenLS , AinsworthAP , LillevangST , QvistN , GeorgsenJ . Leukocyte‐depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double‐blinded, randomized study. International Journal of Colorectal Disease2001;16(3):147‐53. [PUBMED: 11459288] ">Titlestad 2001</a>). Three trials reported 5 × 10<sup>6</sup> leukocytes per unit of blood after leukoreduction (<a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>; <a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>). <a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a> reported 1.2 × 10<sup>9</sup> per unit; <a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a> reported 1.2 ± 1.4 × 10<sup>6</sup> per unit; <a href="./references#CD009745-bbs2-0009" title="TartterPI , MohandasK , AzarP , EndresJ , KaplanJ , SpivackM . Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. American Journal of Surgery1998;176(5):462‐6. [PUBMED: 9874434] ">Tartter 1998</a> reported 2 × 10<sup>5</sup> per unit; and <a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a> less than 2 × 10<sup>4</sup> per unit. Four studies did not report definitions for leukoreduction (<a href="./references#CD009745-bbs2-0008" title="SanfilippoFP , BollingerRR , MacQueenJM , BrooksBJ , KoepkeJA . A randomized study comparing leukocyte‐depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients. Transfusion1985;25(2):116‐9. [PUBMED: 3885483] ">Sanfilippo 1985</a>; <a href="./references#CD009745-bbs2-0012" title="LangeMM , vanHiltenJA , van deWateringLM , BijnenBA , RoumenRM , PutterH , et al. Leucocyte depletion of perioperative blood transfusion does not affect long‐term survival and recurrence in patients with gastrointestinal cancer. The British Journal of Surgery2009;96(7):734‐40. [PUBMED: 19526613] vanHiltenJA , van deWateringLM , vanBockelJH , van deVeldeCJ , KievitJ , BrandR , et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ2004;328(7451):1281. [PUBMED: 15142885] ">van Hilten 2004</a>; <a href="./references#CD009745-bbs2-0002" title="BoshkovLK , ChienG , VanWinkleD , FurnaryAP , WuY , GrunkemeirerGI , et al. Prestorage leukoreduction of transfused packed red cells is associated with significant ongoing 1‐12 month survival benefit cardiac surgery patients. Blood2006;108:578. ">Boshkov 2006</a>; <a href="./references#CD009745-bbs2-0004" title="DonatiA , DamianiE , LuchettiM , DomiziR , ScorcellaC , CarsettiA , et al. Microcirculatory effects of the transfusion of leukodepleted or non‐leukodepleted red blood cells in patients with sepsis: a pilot study. Critical Care2014;18(1):R33. [PUBMED: 24528648] ">Donati 2014</a>). </p> </section> <section id="CD009745-sec-0059"> <h6 class="title">Type of filters</h6> <p>Trials were conducted using different types of filters. Two trials used "Cellselect Optima" filters (<a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>). Four trials used "BPF4" filters for blood leukoreduction (<a href="./references#CD009745-bbs2-0009" title="TartterPI , MohandasK , AzarP , EndresJ , KaplanJ , SpivackM . Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. American Journal of Surgery1998;176(5):462‐6. [PUBMED: 9874434] ">Tartter 1998</a>; <a href="./references#CD009745-bbs2-0010" title="TitlestadIL , EbbesenLS , AinsworthAP , LillevangST , QvistN , GeorgsenJ . Leukocyte‐depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double‐blinded, randomized study. International Journal of Colorectal Disease2001;16(3):147‐53. [PUBMED: 11459288] ">Titlestad 2001</a>; <a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>). <a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a> used "RC 100" filters and two trials used "Sepacell RZ‐200B1" filters (<a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a>; <a href="./references#CD009745-bbs2-0004" title="DonatiA , DamianiE , LuchettiM , DomiziR , ScorcellaC , CarsettiA , et al. Microcirculatory effects of the transfusion of leukodepleted or non‐leukodepleted red blood cells in patients with sepsis: a pilot study. Critical Care2014;18(1):R33. [PUBMED: 24528648] ">Donati 2014</a>). Four trials did not report the type of filter used (<a href="./references#CD009745-bbs2-0008" title="SanfilippoFP , BollingerRR , MacQueenJM , BrooksBJ , KoepkeJA . A randomized study comparing leukocyte‐depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients. Transfusion1985;25(2):116‐9. [PUBMED: 3885483] ">Sanfilippo 1985</a>; <a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>; <a href="./references#CD009745-bbs2-0012" title="LangeMM , vanHiltenJA , van deWateringLM , BijnenBA , RoumenRM , PutterH , et al. Leucocyte depletion of perioperative blood transfusion does not affect long‐term survival and recurrence in patients with gastrointestinal cancer. The British Journal of Surgery2009;96(7):734‐40. [PUBMED: 19526613] vanHiltenJA , van deWateringLM , vanBockelJH , van deVeldeCJ , KievitJ , BrandR , et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ2004;328(7451):1281. [PUBMED: 15142885] ">van Hilten 2004</a>; <a href="./references#CD009745-bbs2-0002" title="BoshkovLK , ChienG , VanWinkleD , FurnaryAP , WuY , GrunkemeirerGI , et al. Prestorage leukoreduction of transfused packed red cells is associated with significant ongoing 1‐12 month survival benefit cardiac surgery patients. Blood2006;108:578. ">Boshkov 2006</a>). </p> </section> <section id="CD009745-sec-0060"> <h6 class="title">Control groups</h6> <p>Trials were conducted using different types of comparator groups. Five trials used "Buffy coat depleted packed cells (PCs)" as a comparison group (<a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a>; <a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>; <a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0012" title="LangeMM , vanHiltenJA , van deWateringLM , BijnenBA , RoumenRM , PutterH , et al. Leucocyte depletion of perioperative blood transfusion does not affect long‐term survival and recurrence in patients with gastrointestinal cancer. The British Journal of Surgery2009;96(7):734‐40. [PUBMED: 19526613] vanHiltenJA , van deWateringLM , vanBockelJH , van deVeldeCJ , KievitJ , BrandR , et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ2004;328(7451):1281. [PUBMED: 15142885] ">van Hilten 2004</a>). Eight trials used "unmodified RBC transfusion" or standard RBCs as a comparison group (<a href="./references#CD009745-bbs2-0008" title="SanfilippoFP , BollingerRR , MacQueenJM , BrooksBJ , KoepkeJA . A randomized study comparing leukocyte‐depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients. Transfusion1985;25(2):116‐9. [PUBMED: 3885483] ">Sanfilippo 1985</a>; <a href="./references#CD009745-bbs2-0009" title="TartterPI , MohandasK , AzarP , EndresJ , KaplanJ , SpivackM . Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. American Journal of Surgery1998;176(5):462‐6. [PUBMED: 9874434] ">Tartter 1998</a>; <a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>; <a href="./references#CD009745-bbs2-0010" title="TitlestadIL , EbbesenLS , AinsworthAP , LillevangST , QvistN , GeorgsenJ . Leukocyte‐depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double‐blinded, randomized study. International Journal of Colorectal Disease2001;16(3):147‐53. [PUBMED: 11459288] ">Titlestad 2001</a>; <a href="./references#CD009745-bbs2-0002" title="BoshkovLK , ChienG , VanWinkleD , FurnaryAP , WuY , GrunkemeirerGI , et al. Prestorage leukoreduction of transfused packed red cells is associated with significant ongoing 1‐12 month survival benefit cardiac surgery patients. Blood2006;108:578. ">Boshkov 2006</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>; <a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a>; <a href="./references#CD009745-bbs2-0004" title="DonatiA , DamianiE , LuchettiM , DomiziR , ScorcellaC , CarsettiA , et al. Microcirculatory effects of the transfusion of leukodepleted or non‐leukodepleted red blood cells in patients with sepsis: a pilot study. Critical Care2014;18(1):R33. [PUBMED: 24528648] ">Donati 2014</a>). One trial also used "Red blood cells concentrate with plasma reduction" as a third non‐leukoreduced arm (<a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>). </p> </section> <section id="CD009745-sec-0061"> <h6 class="title">Cointervention</h6> <p>Three studies described the use of platelets as co‐intervention (<a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>). <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a> reported that platelets were all leukocyte‐depleted by filtration; <a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a> did not describe the platelet leukoreduction process, and <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a> reported that all patients received apheresis platelets when platelets were required. <a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a> reported that none of the patients received platelets concentrate. </p> </section> <section id="CD009745-sec-0062"> <h6 class="title">Outcomes</h6> <p>One trial reported on TRALI (<a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>). </p> <p>Nine trials reported on death from any cause (<a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a>; <a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>; <a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>; <a href="./references#CD009745-bbs2-0010" title="TitlestadIL , EbbesenLS , AinsworthAP , LillevangST , QvistN , GeorgsenJ . Leukocyte‐depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double‐blinded, randomized study. International Journal of Colorectal Disease2001;16(3):147‐53. [PUBMED: 11459288] ">Titlestad 2001</a>; <a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0012" title="LangeMM , vanHiltenJA , van deWateringLM , BijnenBA , RoumenRM , PutterH , et al. Leucocyte depletion of perioperative blood transfusion does not affect long‐term survival and recurrence in patients with gastrointestinal cancer. The British Journal of Surgery2009;96(7):734‐40. [PUBMED: 19526613] vanHiltenJA , van deWateringLM , vanBockelJH , van deVeldeCJ , KievitJ , BrandR , et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ2004;328(7451):1281. [PUBMED: 15142885] ">van Hilten 2004</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>; <a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a>). <a href="./references#CD009745-bbs2-0002" title="BoshkovLK , ChienG , VanWinkleD , FurnaryAP , WuY , GrunkemeirerGI , et al. Prestorage leukoreduction of transfused packed red cells is associated with significant ongoing 1‐12 month survival benefit cardiac surgery patients. Blood2006;108:578. ">Boshkov 2006</a> reported death only for the transfused patients group. </p> <p>Ten trials reported on infection from any cause (<a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a>; <a href="./references#CD009745-bbs2-0009" title="TartterPI , MohandasK , AzarP , EndresJ , KaplanJ , SpivackM . Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. American Journal of Surgery1998;176(5):462‐6. [PUBMED: 9874434] ">Tartter 1998</a>; <a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>; <a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>; <a href="./references#CD009745-bbs2-0010" title="TitlestadIL , EbbesenLS , AinsworthAP , LillevangST , QvistN , GeorgsenJ . Leukocyte‐depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double‐blinded, randomized study. International Journal of Colorectal Disease2001;16(3):147‐53. [PUBMED: 11459288] ">Titlestad 2001</a>; <a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0012" title="LangeMM , vanHiltenJA , van deWateringLM , BijnenBA , RoumenRM , PutterH , et al. Leucocyte depletion of perioperative blood transfusion does not affect long‐term survival and recurrence in patients with gastrointestinal cancer. The British Journal of Surgery2009;96(7):734‐40. [PUBMED: 19526613] vanHiltenJA , van deWateringLM , vanBockelJH , van deVeldeCJ , KievitJ , BrandR , et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ2004;328(7451):1281. [PUBMED: 15142885] ">van Hilten 2004</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>; <a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a>) the infections reported were: respiratory tract infections in six studies (<a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a>; <a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>; <a href="./references#CD009745-bbs2-0010" title="TitlestadIL , EbbesenLS , AinsworthAP , LillevangST , QvistN , GeorgsenJ . Leukocyte‐depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double‐blinded, randomized study. International Journal of Colorectal Disease2001;16(3):147‐53. [PUBMED: 11459288] ">Titlestad 2001</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>; <a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a>); urinary tract infections in five studies (<a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a>; <a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>; <a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a>); wound infections or surgical site infections in seven studies (<a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a>; <a href="./references#CD009745-bbs2-0009" title="TartterPI , MohandasK , AzarP , EndresJ , KaplanJ , SpivackM . Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. American Journal of Surgery1998;176(5):462‐6. [PUBMED: 9874434] ">Tartter 1998</a>; <a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>; <a href="./references#CD009745-bbs2-0010" title="TitlestadIL , EbbesenLS , AinsworthAP , LillevangST , QvistN , GeorgsenJ . Leukocyte‐depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double‐blinded, randomized study. International Journal of Colorectal Disease2001;16(3):147‐53. [PUBMED: 11459288] ">Titlestad 2001</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>; <a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a>); bacteraemia or septicaemia in seven studies (<a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a>; <a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>; <a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>; <a href="./references#CD009745-bbs2-0010" title="TitlestadIL , EbbesenLS , AinsworthAP , LillevangST , QvistN , GeorgsenJ . Leukocyte‐depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double‐blinded, randomized study. International Journal of Colorectal Disease2001;16(3):147‐53. [PUBMED: 11459288] ">Titlestad 2001</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>; <a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a>); abdominal infection in three studies (<a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a>; <a href="./references#CD009745-bbs2-0010" title="TitlestadIL , EbbesenLS , AinsworthAP , LillevangST , QvistN , GeorgsenJ . Leukocyte‐depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double‐blinded, randomized study. International Journal of Colorectal Disease2001;16(3):147‐53. [PUBMED: 11459288] ">Titlestad 2001</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>). <a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a> included persons infected with HIV and CMV. </p> <p>Three trials reported adverse events (<a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>; <a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>; <a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a>). One trial, <a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>, analysed fever episodes per transfusion, but not per study participant, thus it was not included in the meta‐analysis. </p> <p><a href="./references#CD009745-bbs2-0004" title="DonatiA , DamianiE , LuchettiM , DomiziR , ScorcellaC , CarsettiA , et al. Microcirculatory effects of the transfusion of leukodepleted or non‐leukodepleted red blood cells in patients with sepsis: a pilot study. Critical Care2014;18(1):R33. [PUBMED: 24528648] ">Donati 2014</a> and <a href="./references#CD009745-bbs2-0008" title="SanfilippoFP , BollingerRR , MacQueenJM , BrooksBJ , KoepkeJA . A randomized study comparing leukocyte‐depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients. Transfusion1985;25(2):116‐9. [PUBMED: 3885483] ">Sanfilippo 1985</a> reported only physiological outcomes. There were no relevant data to include in the analyses. </p> </section> </section> </section> <section id="CD009745-sec-0063"> <h4 class="title">Excluded studies</h4> <p>We excluded 24 studies (see <a href="./references#CD009745-sec-0131" title="">Characteristics of excluded studies</a>) for the following reasons: </p> <p> <ul id="CD009745-list-0011"> <li> <p>Use of other blood products in the intervention groups (<a href="./references#CD009745-bbs2-0021" title="GilbertGL , HayesK , HudsonIL , JamesJ . Prevention of transfusion‐acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group. Lancet (London, England)1989;1(8649):1228‐31. [PUBMED: 2566781] ">Gilbert 1989</a>; <a href="./references#CD009745-bbs2-0026" title="JensenLS , AndersenAJ , ChristiansenPM , HoklandP , JuhlCO , MadsenG , et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. The British Journal of Surgery1992;79(6):513‐6. [PUBMED: 1611441] JensenLS , HoklandM , NielsenHJ . A randomized controlled study of the effect of bedside leucocyte depletion on the immunosuppressive effect of whole blood transfusion in patients undergoing elective colorectal surgery. The British Journal of Surgery1996;83(7):973‐7. [PUBMED: 8813790] ">Jensen 1992</a>; <a href="./references#CD009745-bbs2-0025" title="HoubiersJG , BrandA , Van DeWateringLM , HermansJ , VerweyPJ , BijnenAB , et al. Randomised controlled trial comparing transfusion of leucocyte‐depleted or buffy‐coat‐depleted blood in surgery for colorectal cancer. Lancet1994;344(8922):573‐8. [PUBMED: 7914960] Van DeWateringLM , BrandA , HoubiersJG , Klein KranenbargWM , HermansJ , Van DeVeldeC . Perioperative blood transfusions, with or without allogeneic leucocytes, relate to survival, not to cancer recurrence. The British Journal of Surgery2001;88(2):267‐72. [PUBMED: 11167879] ">Houbiers 1994</a>; <a href="./references#CD009745-bbs2-0014" title="BowdenRA , SlichterSJ , SayersM , WeisdorfD , CaysM , SchochG , et al. A comparison of filtered leukocyte‐reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion‐associated CMV infection after marrow transplant. Blood1995;86(9):3598‐603. [PUBMED: 7579469] ">Bowden 1995</a>; <a href="./references#CD009745-bbs2-0027" title="KaoKJ , MickelM , BraineHG , DavisK , EnrightH , GernsheimerT , et al. White cell reduction in platelet concentrates and packed red cells by filtration: a multicenter clinical trial. The Trap Study Group. Transfusion1995;35(1):13‐9. [PUBMED: 7998062] ">Kao 1995</a>; <a href="./references#CD009745-bbs2-0022" title="GuYJ , deVriesAJ , BoonstraPW , vanOeverenW . Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. The Journal of Thoracic and Cardiovascular Surgery1996;112(2):494‐500. [PUBMED: 8751518] ">Gu 1996</a>; <a href="./references#CD009745-bbs2-0031" title="NielsenHJ , HammerJH , KrarupAL , NielsenLM , ReimertCM , PedersenAN , et al. Prestorage leukocyte filtration may reduce leukocyte‐derived bioactive substance accumulation in patients operated for burn trauma. Burns1999;25(2):162‐70. [PUBMED: 10208393] ">Nielsen 1999</a>; <a href="./references#CD009745-bbs2-0024" title="HayashiY , SawaY , NishimuraM , IchikawaH , KagisakiK , OhtakeS , et al. Clinical evaluation of leukocyte‐depleted blood cardioplegia for pediatric open heart operation. The Annals of Thoracic Surgery2000;69(6):1914‐9. [PUBMED: 10892946] ">Hayashi 2000</a>; <a href="./references#CD009745-bbs2-0019" title="DzikWH , AndersonJK , O'NeillEM , AssmannSF , KalishLA , StowellCP . A prospective, randomized clinical trial of universal WBC reduction. Transfusion2002;42(9):1114‐22. [PUBMED: 12430666] ">Dzik 2002</a>; <a href="./references#CD009745-bbs2-0020" title="EfstathiouA , VlachveisM , TsonisG , AsteriT , PsarakisA , FessatidisIT . Does leukodepletion during elective cardiac surgery really influence the overall clinical outcome?. The Journal of Cardiovascular Surgery2003;44(2):197‐204. [PUBMED: 12813383] ">Efstathiou 2003</a>; <a href="./references#CD009745-bbs2-0016" title="ConneryCP , ToumpoulisIK , AnagnostopoulosCE , HillelZ , RahmanFG , KatritsisD , et al. Does leukofiltration reduce pulmonary infections in CABG patients? A prospective, randomized study with early results and mid‐term survival. Acta Cardiologica2005;60(3):285‐93. [PUBMED: 15999468] ">Connery 2005</a>; <a href="./references#CD009745-bbs2-0023" title="GuYJ , deVriesAJ , HagenaarsJA , vanOeverenW . Leucocyte filtration of salvaged blood during cardiac surgery: effect on red blood cell function in concentrated blood compared with diluted blood. European Journal of Cardio‐Thoracic Surgery2009;36(5):877‐82. [PUBMED: 19608429] ">Gu 2009</a>). </p> </li> <li> <p>No transfusion in one of the study groups (<a href="./references#CD009745-bbs2-0032" title="OpelzG , VanrenterghemY , KirsteG , GrayDW , HorsburghT , LachanceJG , et al. Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation1997;63(7):964‐7. [PUBMED: 9112348] ">Opelz 1997</a>; <a href="./references#CD009745-bbs2-0018" title="deVriesAJ , GuYJ , vanOeverenW . Leucocyte filtration of residual heart‐lung machine blood in children undergoing congenital heart surgery. Perfusion2004;19(6):345‐9. [PUBMED: 15619967] ">de Vries 2004</a>; <a href="./references#CD009745-bbs2-0028" title="KoskenkariJ , RimpiläinenJ , BiancariF , SurcelHM , KaukorantaP , KiviluomaK , et al. Leukocyte depleting filter attenuates myocardial injury during elective coronary artery bypass surgery. Scandinavian Cardiovascular Journal2005;39(6):358‐68. [PUBMED: 16352489] ">Koskenkari 2005</a>; <a href="./references#CD009745-bbs2-0029" title="Leal‐NovalSR , AmayaR , HerruzoA , HernándezA , OrdóñezA , Marín‐NieblaA , et al. Effects of a leukocyte depleting arterial line filter on perioperative morbidity in patients undergoing cardiac surgery: a controlled randomized trial. The Annals of Thoracic Surgery2005;80(4):1394‐400. [PUBMED: 16181877] ">Leal‐Noval 2005</a>; <a href="./references#CD009745-bbs2-0033" title="SalamonsenRF , AndersonJ , AndersonM , BaileyM , MagrinG , RosenfeldtF . Total leukocyte control for elective coronary bypass surgery does not improve short‐term outcome. The Annals of Thoracic Surgery2005;79(6):2032‐8. [PUBMED: 15919304] ">Salamonsen 2005</a>; <a href="./references#CD009745-bbs2-0035" title="So‐OsmanC , NelissenR , TeSlaaR , CoeneL , BrandR , BrandA . A randomized comparison of transfusion triggers in elective orthopaedic surgery using leucocyte‐depleted red blood cells. Vox Sanguinis2010;98(1):56‐64. [PUBMED: 19656349] ">So‐Osman 2010</a>). </p> </li> <li> <p>Non‐randomised clinical trial (<a href="./references#CD009745-bbs2-0015" title="BraceyAW , RadovancevicR , NussmeierNA . Leukocyte‐depleted blood in open‐heart surgery patients: effects on outcome. Transfusion2002;42(Suppl):5S. ">Bracey 2002</a>; <a href="./references#CD009745-bbs2-0017" title="deVriesAJ , GuYJ , PostWJ , VosP , StokroosI , LipH , et al. Leucocyte depletion during cardiac surgery: a comparison of different filtration strategies. Perfusion2003;18(1):31‐8. [PUBMED: 12705648] ">de Vries 2003</a>; <a href="./references#CD009745-bbs2-0030" title="LlewelynCA , TaylorRS , ToddAA , StevensW , MurphyMF , WilliamsonLM . The effect of universal leukoreduction on postoperative infections and length of hospital stay in elective orthopedic and cardiac surgery. Transfusion2004;44(4):489‐500. [PUBMED: 15043563] ">Llewelyn 2004</a>; <a href="./references#CD009745-bbs2-0034" title="SkånbergJ , LundholmK , HaglindE . Effects of blood transfusion with leucocyte depletion on length of hospital stay, respiratory assistance and survival after curative surgery for colorectal cancer. Acta Oncologica2007;46(8):1123‐30. [PUBMED: 17851860] ">Skånberg 2007</a>), or a review article (<a href="./references#CD009745-bbs2-0037" title="van deWateringL . What has universal leucodepletion given us: evidence from clinical trials?. Vox Sanguinis2004;87 Suppl 2:139‐42. [PUBMED: 15209899] ">van de Watering 2004</a>; <a href="./references#CD009745-bbs2-0036" title="VamvakasEC . White‐blood‐cell‐containing allogeneic blood transfusion and postoperative infection or mortality: an updated meta‐analysis. Vox Sanguinis2007;92(3):224‐32. [PUBMED: 17348871] ">Vamvakas 2007</a>). </p> </li> </ul> </p> </section> </section> <section id="CD009745-sec-0064"> <h3 class="title">Risk of bias in included studies</h3> <p>We have summarised the risk of bias in the included studies in <a href="#CD009745-fig-0002">Figure 2</a> and <a href="#CD009745-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD009745-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies." data-id="CD009745-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD009745-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study." data-id="CD009745-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study. </p> </div> </div> </div> <section id="CD009745-sec-0065"> <h4 class="title">Allocation</h4> <section id="CD009745-sec-0066"> <h5 class="title">Random sequence generation</h5> <p>In five trials there was low risk of bias related to the sequence generation method (<a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0012" title="LangeMM , vanHiltenJA , van deWateringLM , BijnenBA , RoumenRM , PutterH , et al. Leucocyte depletion of perioperative blood transfusion does not affect long‐term survival and recurrence in patients with gastrointestinal cancer. The British Journal of Surgery2009;96(7):734‐40. [PUBMED: 19526613] vanHiltenJA , van deWateringLM , vanBockelJH , van deVeldeCJ , KievitJ , BrandR , et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ2004;328(7451):1281. [PUBMED: 15142885] ">van Hilten 2004</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>; <a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a>). Eight trials had unclear risk of bias (<a href="./references#CD009745-bbs2-0008" title="SanfilippoFP , BollingerRR , MacQueenJM , BrooksBJ , KoepkeJA . A randomized study comparing leukocyte‐depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients. Transfusion1985;25(2):116‐9. [PUBMED: 3885483] ">Sanfilippo 1985</a>; <a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a>; <a href="./references#CD009745-bbs2-0009" title="TartterPI , MohandasK , AzarP , EndresJ , KaplanJ , SpivackM . Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. American Journal of Surgery1998;176(5):462‐6. [PUBMED: 9874434] ">Tartter 1998</a>; <a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>; <a href="./references#CD009745-bbs2-0010" title="TitlestadIL , EbbesenLS , AinsworthAP , LillevangST , QvistN , GeorgsenJ . Leukocyte‐depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double‐blinded, randomized study. International Journal of Colorectal Disease2001;16(3):147‐53. [PUBMED: 11459288] ">Titlestad 2001</a>; <a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>; <a href="./references#CD009745-bbs2-0002" title="BoshkovLK , ChienG , VanWinkleD , FurnaryAP , WuY , GrunkemeirerGI , et al. Prestorage leukoreduction of transfused packed red cells is associated with significant ongoing 1‐12 month survival benefit cardiac surgery patients. Blood2006;108:578. ">Boshkov 2006</a>; <a href="./references#CD009745-bbs2-0004" title="DonatiA , DamianiE , LuchettiM , DomiziR , ScorcellaC , CarsettiA , et al. Microcirculatory effects of the transfusion of leukodepleted or non‐leukodepleted red blood cells in patients with sepsis: a pilot study. Critical Care2014;18(1):R33. [PUBMED: 24528648] ">Donati 2014</a>). </p> </section> <section id="CD009745-sec-0067"> <h5 class="title">Allocation concealment</h5> <p>In five trials there was low risk of bias related to the method of allocation concealment (<a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0012" title="LangeMM , vanHiltenJA , van deWateringLM , BijnenBA , RoumenRM , PutterH , et al. Leucocyte depletion of perioperative blood transfusion does not affect long‐term survival and recurrence in patients with gastrointestinal cancer. The British Journal of Surgery2009;96(7):734‐40. [PUBMED: 19526613] vanHiltenJA , van deWateringLM , vanBockelJH , van deVeldeCJ , KievitJ , BrandR , et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ2004;328(7451):1281. [PUBMED: 15142885] ">van Hilten 2004</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>; <a href="./references#CD009745-bbs2-0004" title="DonatiA , DamianiE , LuchettiM , DomiziR , ScorcellaC , CarsettiA , et al. Microcirculatory effects of the transfusion of leukodepleted or non‐leukodepleted red blood cells in patients with sepsis: a pilot study. Critical Care2014;18(1):R33. [PUBMED: 24528648] ">Donati 2014</a>). Eight trials had unclear risk of bias (<a href="./references#CD009745-bbs2-0008" title="SanfilippoFP , BollingerRR , MacQueenJM , BrooksBJ , KoepkeJA . A randomized study comparing leukocyte‐depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients. Transfusion1985;25(2):116‐9. [PUBMED: 3885483] ">Sanfilippo 1985</a>; <a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a>; <a href="./references#CD009745-bbs2-0009" title="TartterPI , MohandasK , AzarP , EndresJ , KaplanJ , SpivackM . Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. American Journal of Surgery1998;176(5):462‐6. [PUBMED: 9874434] ">Tartter 1998</a>; <a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>; <a href="./references#CD009745-bbs2-0010" title="TitlestadIL , EbbesenLS , AinsworthAP , LillevangST , QvistN , GeorgsenJ . Leukocyte‐depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double‐blinded, randomized study. International Journal of Colorectal Disease2001;16(3):147‐53. [PUBMED: 11459288] ">Titlestad 2001</a>; <a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>; <a href="./references#CD009745-bbs2-0002" title="BoshkovLK , ChienG , VanWinkleD , FurnaryAP , WuY , GrunkemeirerGI , et al. Prestorage leukoreduction of transfused packed red cells is associated with significant ongoing 1‐12 month survival benefit cardiac surgery patients. Blood2006;108:578. ">Boshkov 2006</a>; <a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a>). </p> </section> </section> <section id="CD009745-sec-0068"> <h4 class="title">Blinding</h4> <section id="CD009745-sec-0069"> <h5 class="title">Blinding of participants and personnel</h5> <p>The risk of bias arising from the lack of blinding was rated as low in six trials (<a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>; <a href="./references#CD009745-bbs2-0010" title="TitlestadIL , EbbesenLS , AinsworthAP , LillevangST , QvistN , GeorgsenJ . Leukocyte‐depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double‐blinded, randomized study. International Journal of Colorectal Disease2001;16(3):147‐53. [PUBMED: 11459288] ">Titlestad 2001</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0012" title="LangeMM , vanHiltenJA , van deWateringLM , BijnenBA , RoumenRM , PutterH , et al. Leucocyte depletion of perioperative blood transfusion does not affect long‐term survival and recurrence in patients with gastrointestinal cancer. The British Journal of Surgery2009;96(7):734‐40. [PUBMED: 19526613] vanHiltenJA , van deWateringLM , vanBockelJH , van deVeldeCJ , KievitJ , BrandR , et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ2004;328(7451):1281. [PUBMED: 15142885] ">van Hilten 2004</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>; <a href="./references#CD009745-bbs2-0004" title="DonatiA , DamianiE , LuchettiM , DomiziR , ScorcellaC , CarsettiA , et al. Microcirculatory effects of the transfusion of leukodepleted or non‐leukodepleted red blood cells in patients with sepsis: a pilot study. Critical Care2014;18(1):R33. [PUBMED: 24528648] ">Donati 2014</a>). The risk of bias from blinding was unclear in five trials (<a href="./references#CD009745-bbs2-0008" title="SanfilippoFP , BollingerRR , MacQueenJM , BrooksBJ , KoepkeJA . A randomized study comparing leukocyte‐depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients. Transfusion1985;25(2):116‐9. [PUBMED: 3885483] ">Sanfilippo 1985</a>; <a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a>; <a href="./references#CD009745-bbs2-0009" title="TartterPI , MohandasK , AzarP , EndresJ , KaplanJ , SpivackM . Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. American Journal of Surgery1998;176(5):462‐6. [PUBMED: 9874434] ">Tartter 1998</a>; <a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>; <a href="./references#CD009745-bbs2-0002" title="BoshkovLK , ChienG , VanWinkleD , FurnaryAP , WuY , GrunkemeirerGI , et al. Prestorage leukoreduction of transfused packed red cells is associated with significant ongoing 1‐12 month survival benefit cardiac surgery patients. Blood2006;108:578. ">Boshkov 2006</a>) and high in two studies (<a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>; <a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a>). </p> </section> <section id="CD009745-sec-0070"> <h5 class="title">Blinding outcome assessment</h5> <p>Eight trials had a low risk of bias arising from the method of blinding outcome assessment (<a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a>; <a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>; <a href="./references#CD009745-bbs2-0010" title="TitlestadIL , EbbesenLS , AinsworthAP , LillevangST , QvistN , GeorgsenJ . Leukocyte‐depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double‐blinded, randomized study. International Journal of Colorectal Disease2001;16(3):147‐53. [PUBMED: 11459288] ">Titlestad 2001</a>; <a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0002" title="BoshkovLK , ChienG , VanWinkleD , FurnaryAP , WuY , GrunkemeirerGI , et al. Prestorage leukoreduction of transfused packed red cells is associated with significant ongoing 1‐12 month survival benefit cardiac surgery patients. Blood2006;108:578. ">Boshkov 2006</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>; <a href="./references#CD009745-bbs2-0004" title="DonatiA , DamianiE , LuchettiM , DomiziR , ScorcellaC , CarsettiA , et al. Microcirculatory effects of the transfusion of leukodepleted or non‐leukodepleted red blood cells in patients with sepsis: a pilot study. Critical Care2014;18(1):R33. [PUBMED: 24528648] ">Donati 2014</a>). Four studies were at unclear risk (<a href="./references#CD009745-bbs2-0008" title="SanfilippoFP , BollingerRR , MacQueenJM , BrooksBJ , KoepkeJA . A randomized study comparing leukocyte‐depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients. Transfusion1985;25(2):116‐9. [PUBMED: 3885483] ">Sanfilippo 1985</a>; <a href="./references#CD009745-bbs2-0009" title="TartterPI , MohandasK , AzarP , EndresJ , KaplanJ , SpivackM . Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. American Journal of Surgery1998;176(5):462‐6. [PUBMED: 9874434] ">Tartter 1998</a>; <a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>; <a href="./references#CD009745-bbs2-0012" title="LangeMM , vanHiltenJA , van deWateringLM , BijnenBA , RoumenRM , PutterH , et al. Leucocyte depletion of perioperative blood transfusion does not affect long‐term survival and recurrence in patients with gastrointestinal cancer. The British Journal of Surgery2009;96(7):734‐40. [PUBMED: 19526613] vanHiltenJA , van deWateringLM , vanBockelJH , van deVeldeCJ , KievitJ , BrandR , et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ2004;328(7451):1281. [PUBMED: 15142885] ">van Hilten 2004</a>) and one trial was at high risk of bias (<a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a>). </p> </section> </section> <section id="CD009745-sec-0071"> <h4 class="title">Incomplete outcome data</h4> <p>Ten trials were judged to be at low risk of bias from incomplete outcome data (<a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a>; <a href="./references#CD009745-bbs2-0009" title="TartterPI , MohandasK , AzarP , EndresJ , KaplanJ , SpivackM . Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. American Journal of Surgery1998;176(5):462‐6. [PUBMED: 9874434] ">Tartter 1998</a>; <a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>; <a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>; <a href="./references#CD009745-bbs2-0010" title="TitlestadIL , EbbesenLS , AinsworthAP , LillevangST , QvistN , GeorgsenJ . Leukocyte‐depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double‐blinded, randomized study. International Journal of Colorectal Disease2001;16(3):147‐53. [PUBMED: 11459288] ">Titlestad 2001</a>; <a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>; <a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a>; <a href="./references#CD009745-bbs2-0004" title="DonatiA , DamianiE , LuchettiM , DomiziR , ScorcellaC , CarsettiA , et al. Microcirculatory effects of the transfusion of leukodepleted or non‐leukodepleted red blood cells in patients with sepsis: a pilot study. Critical Care2014;18(1):R33. [PUBMED: 24528648] ">Donati 2014</a>). There was unclear risk of bias in two trials (<a href="./references#CD009745-bbs2-0008" title="SanfilippoFP , BollingerRR , MacQueenJM , BrooksBJ , KoepkeJA . A randomized study comparing leukocyte‐depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients. Transfusion1985;25(2):116‐9. [PUBMED: 3885483] ">Sanfilippo 1985</a>; <a href="./references#CD009745-bbs2-0002" title="BoshkovLK , ChienG , VanWinkleD , FurnaryAP , WuY , GrunkemeirerGI , et al. Prestorage leukoreduction of transfused packed red cells is associated with significant ongoing 1‐12 month survival benefit cardiac surgery patients. Blood2006;108:578. ">Boshkov 2006</a>), and high risk of bias in one trial (<a href="./references#CD009745-bbs2-0012" title="LangeMM , vanHiltenJA , van deWateringLM , BijnenBA , RoumenRM , PutterH , et al. Leucocyte depletion of perioperative blood transfusion does not affect long‐term survival and recurrence in patients with gastrointestinal cancer. The British Journal of Surgery2009;96(7):734‐40. [PUBMED: 19526613] vanHiltenJA , van deWateringLM , vanBockelJH , van deVeldeCJ , KievitJ , BrandR , et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ2004;328(7451):1281. [PUBMED: 15142885] ">van Hilten 2004</a>). </p> </section> <section id="CD009745-sec-0072"> <h4 class="title">Selective reporting</h4> <p>We judged nine trials as at low risk of reporting bias (<a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a>; <a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>; <a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>; <a href="./references#CD009745-bbs2-0010" title="TitlestadIL , EbbesenLS , AinsworthAP , LillevangST , QvistN , GeorgsenJ . Leukocyte‐depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double‐blinded, randomized study. International Journal of Colorectal Disease2001;16(3):147‐53. [PUBMED: 11459288] ">Titlestad 2001</a>; <a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0012" title="LangeMM , vanHiltenJA , van deWateringLM , BijnenBA , RoumenRM , PutterH , et al. Leucocyte depletion of perioperative blood transfusion does not affect long‐term survival and recurrence in patients with gastrointestinal cancer. The British Journal of Surgery2009;96(7):734‐40. [PUBMED: 19526613] vanHiltenJA , van deWateringLM , vanBockelJH , van deVeldeCJ , KievitJ , BrandR , et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ2004;328(7451):1281. [PUBMED: 15142885] ">van Hilten 2004</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>; <a href="./references#CD009745-bbs2-0004" title="DonatiA , DamianiE , LuchettiM , DomiziR , ScorcellaC , CarsettiA , et al. Microcirculatory effects of the transfusion of leukodepleted or non‐leukodepleted red blood cells in patients with sepsis: a pilot study. Critical Care2014;18(1):R33. [PUBMED: 24528648] ">Donati 2014</a>). Two trials were at unclear risk of bias (<a href="./references#CD009745-bbs2-0002" title="BoshkovLK , ChienG , VanWinkleD , FurnaryAP , WuY , GrunkemeirerGI , et al. Prestorage leukoreduction of transfused packed red cells is associated with significant ongoing 1‐12 month survival benefit cardiac surgery patients. Blood2006;108:578. ">Boshkov 2006</a>; <a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a>), and two trials were at high risk of bias (<a href="./references#CD009745-bbs2-0008" title="SanfilippoFP , BollingerRR , MacQueenJM , BrooksBJ , KoepkeJA . A randomized study comparing leukocyte‐depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients. Transfusion1985;25(2):116‐9. [PUBMED: 3885483] ">Sanfilippo 1985</a>; <a href="./references#CD009745-bbs2-0009" title="TartterPI , MohandasK , AzarP , EndresJ , KaplanJ , SpivackM . Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. American Journal of Surgery1998;176(5):462‐6. [PUBMED: 9874434] ">Tartter 1998</a>). </p> </section> <section id="CD009745-sec-0073"> <h4 class="title">Other potential sources of bias</h4> <p>Six trials appeared free of other potential sources of bias and we judged these trials to be at low risk of bias (<a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>; <a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>; <a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>; <a href="./references#CD009745-bbs2-0004" title="DonatiA , DamianiE , LuchettiM , DomiziR , ScorcellaC , CarsettiA , et al. Microcirculatory effects of the transfusion of leukodepleted or non‐leukodepleted red blood cells in patients with sepsis: a pilot study. Critical Care2014;18(1):R33. [PUBMED: 24528648] ">Donati 2014</a>). Seven trials had design bias of different kinds: inconsistency in adequately determining inclusion criteria, premature randomisation (<a href="./references#CD009745-bbs2-0008" title="SanfilippoFP , BollingerRR , MacQueenJM , BrooksBJ , KoepkeJA . A randomized study comparing leukocyte‐depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients. Transfusion1985;25(2):116‐9. [PUBMED: 3885483] ">Sanfilippo 1985</a>; <a href="./references#CD009745-bbs2-0009" title="TartterPI , MohandasK , AzarP , EndresJ , KaplanJ , SpivackM . Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. American Journal of Surgery1998;176(5):462‐6. [PUBMED: 9874434] ">Tartter 1998</a>; <a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>; <a href="./references#CD009745-bbs2-0010" title="TitlestadIL , EbbesenLS , AinsworthAP , LillevangST , QvistN , GeorgsenJ . Leukocyte‐depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double‐blinded, randomized study. International Journal of Colorectal Disease2001;16(3):147‐53. [PUBMED: 11459288] ">Titlestad 2001</a>; <a href="./references#CD009745-bbs2-0012" title="LangeMM , vanHiltenJA , van deWateringLM , BijnenBA , RoumenRM , PutterH , et al. Leucocyte depletion of perioperative blood transfusion does not affect long‐term survival and recurrence in patients with gastrointestinal cancer. The British Journal of Surgery2009;96(7):734‐40. [PUBMED: 19526613] vanHiltenJA , van deWateringLM , vanBockelJH , van deVeldeCJ , KievitJ , BrandR , et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ2004;328(7451):1281. [PUBMED: 15142885] ">van Hilten 2004</a>; <a href="./references#CD009745-bbs2-0002" title="BoshkovLK , ChienG , VanWinkleD , FurnaryAP , WuY , GrunkemeirerGI , et al. Prestorage leukoreduction of transfused packed red cells is associated with significant ongoing 1‐12 month survival benefit cardiac surgery patients. Blood2006;108:578. ">Boshkov 2006</a>) or sample size bias (<a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a>). </p> </section> </section> <section id="CD009745-sec-0074"> <h3 class="title" id="CD009745-sec-0074">Effects of interventions</h3> <p>See: <a href="./full#CD009745-tbl-0001"><b>Summary of findings for the main comparison</b> Leukoreduced PRBCs versus non‐leukoreduced PRBCs for preventing adverse reaction from allogeneic blood transfusion</a> </p> <section id="CD009745-sec-0075"> <h4 class="title">Leukoreduced PRBC versus non‐leukoreduced PRBC</h4> <section id="CD009745-sec-0076"> <h5 class="title">1. Primary outcomes</h5> <section id="CD009745-sec-0077"> <h6 class="title">TRALI (analysis based on total randomised patients)</h6> <section id="CD009745-sec-0078"> <p><b>Overall analysis</b></p> <p>One trial including 1864 participants showed no difference between treatment groups on TRALI (6.02% versus 6.31%) (RR 0.96, 95% CI 0.67 to 1.36; P = 0.80) (<a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>). See <a href="./references#CD009745-fig-0008" title="">Analysis 1.1</a>. </p> </section> <section id="CD009745-sec-0079"> <p><b>Quality of evidence (TSA and GRADE)</b></p> <p>The accrued information of 1864 participants constituted only 28.5% of the diversity‐adjusted required information size (DARIS) of 6548 participants. We calculated DARIS based on a diversity of 4%; a proportion with the TRALI events of 6.3% in the control group; a relative risk reduction of 25%; an alpha of 5%; and a beta of 20% (power = 80%). With the inclusion of data from one trial, the Z‐value neither crossed the conventional statistical boundaries of 5% nor the Lan‐DeMets‐O'Brian‐Fleming boundaries. The TSA‐adjusted 95% CI overlapped with no effect (RR 1.0) and is compatible with both a potential benefit and a potential harm (RR 0.46 and RR 1.98, respectively); thus, the TSA yielded an inconclusive result. The quality of evidence was low (imprecision as reflected in the wide CI and only one trial with a small sample size as compared with the DARIS (‐2)). </p> <p>In the analysis including "only transfused patients", compared to all patients results were similar (RR 0.98, 95% CI 0.74 to 1.29; P = 0.87; <a href="./references#CD009745-fig-0012" title="">Analysis 2.1</a>). We were unable to conduct other subgroup and sensitivity analyses because only one study measured this outcome. In this study, <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>, leukoreduction was performed pre‐storage. </p> </section> </section> </section> <section id="CD009745-sec-0080"> <h5 class="title">2. Secondary outcomes</h5> <section id="CD009745-sec-0081"> <h6 class="title">Death due to any cause</h6> <section id="CD009745-sec-0082"> <p><b>Overall analysis (total randomised patients)</b></p> <p>The meta‐analysis of nine trials including 6485 participants showed no difference between treatment groups in the risk of death from any cause (8.54% versus 9.34%; RR 0.81, 95% CI 0.58 to 1.12, I² statistic = 63%, P = 0.20) (<a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a>; <a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>; <a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>; <a href="./references#CD009745-bbs2-0010" title="TitlestadIL , EbbesenLS , AinsworthAP , LillevangST , QvistN , GeorgsenJ . Leukocyte‐depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double‐blinded, randomized study. International Journal of Colorectal Disease2001;16(3):147‐53. [PUBMED: 11459288] ">Titlestad 2001</a>; <a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0012" title="LangeMM , vanHiltenJA , van deWateringLM , BijnenBA , RoumenRM , PutterH , et al. Leucocyte depletion of perioperative blood transfusion does not affect long‐term survival and recurrence in patients with gastrointestinal cancer. The British Journal of Surgery2009;96(7):734‐40. [PUBMED: 19526613] vanHiltenJA , van deWateringLM , vanBockelJH , van deVeldeCJ , KievitJ , BrandR , et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ2004;328(7451):1281. [PUBMED: 15142885] ">van Hilten 2004</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>; <a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a>). See <a href="./references#CD009745-fig-0009" title="">Analysis 1.2</a>. </p> </section> <section id="CD009745-sec-0083"> <p><b>Sensitivity analysis</b></p> <p>We conducted three sensitivity analyses; none of which were statistically significant. The RRs using the fixed‐effect model were similar to that of the random effect model. </p> <p> <ol id="CD009745-list-0012"> <li> <p>Including three studies with low risk of bias (<a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>), compared to six studies at unclear or high risk of bias (RR 1.03, 95% CI 0.89 to 1.20; I² statistic = 38%, P = 0.66). </p> </li> <li> <p>Including "only transfused patients", compared to all patients (RR 0.80, 95% CI 0.60 to 1.07, I² statistic: 60%, P = 0.13, <a href="./references#CD009745-fig-0013" title="">Analysis 2.2</a>). </p> </li> <li> <p>Post‐storage leukoreduction, compared with pre‐storage leukoreduction (RR 0.74, 95% CI 0.53 to 1.04, I² statistic: 70%, P = 0.09). </p> </li> </ol> </p> </section> <section id="CD009745-sec-0084"> <p><b>Reporting bias</b></p> <p>We did not explore reporting biases since the meta‐analysis included fewer than 10 studies (<a href="./references#CD009745-bbs2-0076" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0[updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD009745-sec-0085"> <p><b>Quality of evidence (TSA and GRADE)</b></p> <p>The accrued information of 6485 participants constituted only 55.2% of the DARIS of 11,735 participants. DARIS was calculated based on a diversity of 84%; a proportion of death from any cause of 9.34% in the control group (median proportion of deaths in the control group); a relative risk reduction of 25%; an alpha of 5%; and a beta of 20% (power = 80%). The Z‐value neither crossed the conventional statistical boundaries of 5% nor the Lan‐DeMets‐O'Brian‐Fleming boundaries. The TSA did not indicate futility, as the cumulative Z‐curve did not cross the futility wedge (<a href="#CD009745-fig-0004">Figure 4</a>). The TSA‐adjusted 95% CI overlapped with no effect (RR 1.0) and is compatible with both a potential benefit and a potential harm (RR 0.51 and RR 1.27, respectively); thus, the TSA yielded an inconclusive result. The quality of evidence was very low (high risk of bias (‐1); important heterogeneity (‐1); and imprecision as reflected in the wide CI and an insufficient accrued information size compared with the DARIS (‐1)). </p> <div class="figure" id="CD009745-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="TSA calculated to reliably detect a 25% relative change in the incidence of death from any cause, assuming a control group event rate of 9.34% with a power of 80% at an alpha of 5%" data-id="CD009745-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>TSA calculated to reliably detect a 25% relative change in the incidence of death from any cause, assuming a control group event rate of 9.34% with a power of 80% at an alpha of 5% </p> </div> </div> </div> </section> </section> <section id="CD009745-sec-0086"> <h6 class="title">Infection from any cause</h6> <section id="CD009745-sec-0087"> <p><b>Overall analysis (total randomised patients)</b></p> <p>The meta‐analysis of 10 trials involving 6709 participants showed no difference between treatment groups in the risk of infection from any cause (17.7% versus 20.4%; RR 0.80, 95% CI 0.62 to 1.03; I² statistic = 84%, P = 0.08) (<a href="./references#CD009745-bbs2-0005" title="JensenLS , Kissmeyer‐NielsenP , WolffB , QvistN . Randomised comparison of leucocyte‐depleted versus buffy‐coat‐poor blood transfusion and complications after colorectal surgery. Lancet1996;348(9031):841‐5. [PUBMED: 8826808] ">Jensen 1996</a>; <a href="./references#CD009745-bbs2-0009" title="TartterPI , MohandasK , AzarP , EndresJ , KaplanJ , SpivackM . Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. American Journal of Surgery1998;176(5):462‐6. [PUBMED: 9874434] ">Tartter 1998</a>; <a href="./references#CD009745-bbs2-0011" title="van deWateringLM , HermansJ , HoubiersJG , van denBroekPJ , BouterH , BoerF , et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation1998;97(6):562‐8. [PUBMED: 9494026] ">van de Watering 1998</a>; <a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>; <a href="./references#CD009745-bbs2-0010" title="TitlestadIL , EbbesenLS , AinsworthAP , LillevangST , QvistN , GeorgsenJ . Leukocyte‐depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double‐blinded, randomized study. International Journal of Colorectal Disease2001;16(3):147‐53. [PUBMED: 11459288] ">Titlestad 2001</a>; <a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0012" title="LangeMM , vanHiltenJA , van deWateringLM , BijnenBA , RoumenRM , PutterH , et al. Leucocyte depletion of perioperative blood transfusion does not affect long‐term survival and recurrence in patients with gastrointestinal cancer. The British Journal of Surgery2009;96(7):734‐40. [PUBMED: 19526613] vanHiltenJA , van deWateringLM , vanBockelJH , van deVeldeCJ , KievitJ , BrandR , et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ2004;328(7451):1281. [PUBMED: 15142885] ">van Hilten 2004</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>; <a href="./references#CD009745-bbs2-0006" title="LapierreV , AupérinA , RobinetE , FerrandC , OubouzarN , TramalloniD , et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion2007;47(9):1691‐9. [PUBMED: 17725736] ">Lapierre 2007</a>). See <a href="./references#CD009745-fig-0010" title="">Analysis 1.3</a>. </p> </section> <section id="CD009745-sec-0088"> <p><b>Sensitivity analysis</b></p> <p>The RR was different when we used the fixed‐effect model (RR 0.85, 95% CI 0.77 to 0.93; I² statistic = 84%, P = 0.0006); however, the results of TSA indicate this statistically significant result may be a spurious finding. </p> <p>We performed three other sensitivity analyses, which showed no statistically significant differences: </p> <p> <ol id="CD009745-list-0013"> <li> <p>Including three studies with low risk of bias (<a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>; <a href="./references#CD009745-bbs2-0001" title="BilginYM , Van DeWateringLM , EijsmanL , VersteeghMI , BrandR , VanOersMH , et al. Double‐blind, randomized controlled trial on the effect of leukocyte‐depleted erythrocyte transfusions in cardiac valve surgery. Circulation2004;109(22):2755‐60. [PUBMED: 15148271] ">Bilgin 2004</a>; <a href="./references#CD009745-bbs2-0007" title="NathensAB , NesterTA , RubenfeldGD , NirulaR , GernsheimerTB . The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock2006;26(4):342‐7. [PUBMED: 16980879] WatkinsTR , RubenfeldGD , MartinTR , NesterTA , CaldwellE , BillgrenJ , et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Critical Care Medicine2008;36(5):1493‐9. [PUBMED: 18434890] ">Nathens 2006</a>), compared with seven studies at unclear or high risk of bias (RR 0.92, 95% CI 0.63 to 1.34; I² statistic = 83%, P = 0.67). </p> </li> <li> <p>Including "only transfused patients", compared with all randomised patients (RR 0.76, 95% CI 0.58 to 1.00; I² statistic = 87%, P = 0.05, <a href="./references#CD009745-fig-0014" title="">Analysis 2.3</a>), and the heterogeneity remained high. </p> </li> <li> <p>Post‐storage leukoreduction, compared with pre‐storage leukoreduction (RR 0.91, 95% CI 0.76 to 1.09; I² statistic = 65%, P = 0.32). </p> </li> </ol> </p> </section> <section id="CD009745-sec-0089"> <p><b>Reporting bias</b></p> <p>After visual assessment of the funnel plot (<a href="#CD009745-fig-0005">Figure 5</a>) and a formal assessment of the funnel plot asymmetry, applying the Egger's test (P = 0.09), we found no sign of reporting bias. </p> <div class="figure" id="CD009745-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Leukoreduced PRBC versus non‐leukoreduced PRBC. Main Analysis (Randomised patients), outcome: 1.3 Infection. Number of events of the total of randomised patients reported." data-id="CD009745-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Leukoreduced PRBC versus non‐leukoreduced PRBC. Main Analysis (Randomised patients), outcome: 1.3 Infection. Number of events of the total of randomised patients reported. </p> </div> </div> </div> </section> <section id="CD009745-sec-0090"> <p><b>Quality of evidence (TSA and GRADE)</b></p> <p>The accrued information of 6709 participants constituted only 60.6% of the DARIS of 11,062 participants. We calculated DARIS based on a diversity of 86%; a proportion of infection from any cause of 20.4% in the control group (median proportion in the control group); a relative risk reduction of 25%; an alpha of 5%; and a beta of 20% (power = 80%). The Z‐value neither crossed the conventional statistical boundaries of 5% nor the Lan‐DeMets‐O'Brian‐Fleming boundaries. TSA did not indicate futility, as the Z‐curve did not cross the futility wedge (<a href="#CD009745-fig-0006">Figure 6</a>). The TSA‐adjusted 95% CI overlapped the zone of no effect (RR 1.0) and is compatible with both a potential benefit and a potential harm (RR 0.57 and RR 1.12, respectively); thus, the TSA yielded an inconclusive result. The quality of evidence was very low (high risk of bias (‐1); important heterogeneity (‐2); and imprecision due to the CI crossing the threshold of meaningful effect and an insufficient sample size as compared with the DARIS (‐1)). </p> <div class="figure" id="CD009745-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="TSA calculated to reliably detect a 25% relative change in the incidence of infection from any cause, assuming a control group event rate of 20.4% with a power of 80% at an alpha of 5%." data-id="CD009745-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>TSA calculated to reliably detect a 25% relative change in the incidence of infection from any cause, assuming a control group event rate of 20.4% with a power of 80% at an alpha of 5%. </p> </div> </div> </div> </section> </section> <section id="CD009745-sec-0091"> <h6 class="title">Adverse events (fever)</h6> <p>Three trials reported adverse events. However, we excluded one trial reporting fever as a temperature increase of at least 1°C per transfusion from the meta‐analysis since fever was not analysed per study participant (<a href="./references#CD009745-bbs2-0003" title="CollierAC , KalishLA , BuschMP , GernsheimerT , AssmannSF , LaneTA , et al. Leukocyte‐reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA2001;285(12):1592‐601. [PUBMED: 11268267] LaneTA , GernsheimerT , MohandasK , AssmannSF . Signs and symptoms associated with the transfusion of WBC‐reduced RBCs and non‐WBC‐reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study. Transfusion2002;42(2):265‐74. [PUBMED: 11896345] ">Collier 2001</a>). </p> <section id="CD009745-sec-0092"> <p><b>Overall analysis (total randomised patients)</b></p> <p>Two trials including 634 participants showed no difference between treatment groups in adverse events (31.9% versus 38.7%; RR 0.81, 95% CI 0.64 to 1.02; I² statistic = 0%, P = 0.07) (<a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>). See <a href="./references#CD009745-fig-0011" title="">Analysis 1.4</a>. </p> </section> <section id="CD009745-sec-0093"> <p><b>Sensitivity analysis</b></p> <p>In the sensitivity analysis comparing "transfused patients" with randomised patients, there was a statistically significant difference (RR 0.75, 95% CI 0.60 to 0.94, I² statistic = 0%, P = 0.01, <a href="./references#CD009745-fig-0015" title="">Analysis 2.4</a>); however, the results of TSA indicate this statistically significant result may be a spurious finding. </p> <p>In a sensitivity analysis of data from one study, <a href="./references#CD009745-bbs2-0013" title="WallisJP , ChapmanCE , OrrKE , ClarkSC , FortyJR . Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion2002;42(9):1127‐34. [PUBMED: 12430668] ">Wallis 2002</a>, there was no difference when comparing post‐storage with pre‐storage leukoreduction (RR 0.81, 95% CI 0.64 to 1.04). </p> </section> <section id="CD009745-sec-0094"> <p><b>Reporting bias</b></p> <p>We did not explore reporting biases since the meta‐analysis included fewer than 10 studies (<a href="./references#CD009745-bbs2-0076" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0[updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD009745-sec-0095"> <p><b>Quality of evidence (TSA and GRADE)</b></p> <p>The accrued information of 634 participants constituted only 84.4% of the DARIS of 751 participants. DARIS was calculated based on a diversity of 0%; a proportion of infection from any cause of 38.7% in the control group (median proportion in the control group); a relative risk reduction of 25%; an alpha of 5%; and a beta of 20% (power = 80%). The Z‐value neither crossed the conventional statistical boundaries of 5% nor the Lan‐DeMets‐O'Brian‐Fleming boundaries. TSA did not indicate futility, as the Z‐curve did not cross the futility wedge (<a href="#CD009745-fig-0007">Figure 7</a>). The TSA‐adjusted 95% CI overlapped with the zone of no effect (RR 1.0) and is compatible with both a potential benefit and a potential harm (RR 0.68 and RR 1.05, respectively); thus, the TSA yielded an inconclusive result. The quality of evidence was low (high risk of bias (‐1); and imprecision due to the CI crossing the threshold of meaningful effect and an insufficient sample size as compared with the DARIS (‐1)). </p> <div class="figure" id="CD009745-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="TSA calculated to reliably detect a 25% relative change in the incidence of fever, assuming a control group event rate of 38.7% with a power of 80% at an alpha of 5%." data-id="CD009745-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>TSA calculated to reliably detect a 25% relative change in the incidence of fever, assuming a control group event rate of 38.7% with a power of 80% at an alpha of 5%. </p> </div> </div> </div> </section> </section> <section id="CD009745-sec-0096"> <h6 class="title">Non‐infectious complications</h6> <p>The included trials did not assess this pre‐defined outcome.</p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009745-sec-0097" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009745-sec-0097">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009745-sec-0151">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009745-sec-0097"></div> <section id="CD009745-sec-0098"> <h3 class="title" id="CD009745-sec-0098">Summary of main results</h3> <p>In this systematic review we included 13 trials involving cardiovascular surgical, gastro‐oncology surgery, trauma and HIV patients who were randomised to receive leukoreduced compared with non‐leukoreduced PRBC transfusion. After analysis of the study data, we are unable to conclude whether or not leukoreduction of PRBC has an effect on preventing TRALI (one trial), death (nine trials), infection (10 trials) and other adverse events (fever, reported in two trials). The quality of evidence was low (TRALI and adverse events) to very low (death and infection) due to high heterogeneity, imprecision and high risk of bias. None of the included trials reported on other non‐infectious complications. The sensitivity analyses of trials at low risk of bias showed neither a beneficial or harmful effect of leukoreduction of PRBC on the pooled data regarding death, infection and adverse events. </p> </section> <section id="CD009745-sec-0099"> <h3 class="title" id="CD009745-sec-0099">Overall completeness and applicability of evidence</h3> <section id="CD009745-sec-0100"> <h4 class="title">Overall completeness of evidence</h4> <p>We analysed 13 controlled clinical trials that met our predefined inclusion criteria. Two trials reported only physiological results and we excluded them from the meta‐analyses. Only one RCT evaluated the primary outcome (TRALI). However, we obtained data from 11 trials which contributed to the effect estimates of the secondary outcomes (death from any cause, infection from any cause and adverse events/fever). We found no trials evaluating non‐infectious complications other than TRALI (e.g. FNHTR). Therefore, the pre‐specified objectives and outcomes of our Cochrane review were partially addressed and the results are inconclusive. Consequently, the findings of this review should be interpreted with caution until more data are available. </p> </section> <section id="CD009745-sec-0101"> <h4 class="title">Applicability of evidence</h4> <p>This Cochrane review is complex for a variety of reasons:</p> <p>Firstly, regarding the population: the identified studies enrolled patients with different health problems, including trauma, cancer, cardiac disease and HIV‐infected patients. Some important patient populations were not studied at all (e.g. paediatric or obstetric patients) or were insufficiently assessed (e.g. one RCT of trauma patients). In this context, external validity may be limited due to a lack of studies analysing these populations. Furthermore, the effect of leukoreduction on some types of patients without a strong indication for leukoreduced PRBC has not been sufficiently evaluated: single‐transfused patients, patients without history of FNHTR, patients who are not receiving long‐term platelet transfusions and those who are not at risk of developing CMV disease. </p> <p>Secondly, regarding the intervention, the included studies did not adequately report several aspects related to the transfusion of RBC that need to be considered when interpreting the results, namely: the use of leukoreduced or non‐leukoreduced platelets as a co‐intervention, the timing of leukoreduction (i.e. pre‐storage or post‐storage), the type of filter used (e.g. Cell select Optima, BPF4, RC 100, Sepacell RZ‐200B1), leucocyte reduction definition (e.g. 0.1 to 0.3 × 10<sup>6</sup> WBC/unit, 5 × 10<sup>6</sup>, 2 × 10<sup>5</sup> per unit, etc.) and the type of transfusion (i.e. allogeneic or autologous). </p> <p>Thirdly, regarding the outcomes: not all the included trials assessed relevant clinical outcomes. Relevant infections (e.g. CMV), non‐infectious complications (e.g. TRALI, FNHTR) and any other adverse events were not sufficiently assessed or reported (<a href="./references#CD009745-bbs2-0095" title="SchulzKF , AltmanDG , MoherD , CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Medicine2010;8:18. [PUBMED: 20334633] ">Schulz 2010</a>). The various follow‐up intervals (28 days to 15 months) may represent another limitation for the assessment of outcomes. </p> <p>Fourthly, regarding the costs: leukoreduction is widely implemented in clinical practice in many countries and some countries have established universal leukoreduction for blood transfusions (<a href="./references#CD009745-bbs2-0080" title="LaupacisA , BrownJ , CostelloB , DelageG , FreedmanJ , HumeH , et al. Prevention of posttransfusion CMV in the era of universal WBC reduction: a consensus statement. Transfusion2001;41(4):560‐9. [PUBMED: 11316911] ">Laupacis 2001</a>). However, the high costs related to this procedure deserve special attention. Even though the reintroduction of non‐leukoreduced products probably provides no clinical impact, it does entail economic consequences. Changing the strategy from performing universal to selective leukoreduction would result in an important decrease in the costs (e.g. almost EUR 30 million per year in Spain (<a href="./references#CD009745-bbs2-0041" title="AguadoM , VillegasR , MárquezS , CorbachoB , NavarroJ . Universal leukorreduction. A systematic review of the literature and an economic assessment. Executive summary [Leucorreducción universal de productos sanguíneos. Revisión Sistemática de la Literatura y Evaluación Económica.]. Agencia de Evaluación de Tecnologías Sanitarias de Andalucía2007:1‐95. ">AETSA 2007</a>)). <a href="./references#CD009745-bbs2-0106" title="TsantesAE , KyriakouE , NikolopoulosGK , StylosD , SidhomM , BonovasS , et al. Cost‐effectiveness of leucoreduction for prevention of febrile non‐haemolytic transfusion reactions. Blood Transfusion2014;12(2):232‐7. [PUBMED: 24931843] ">Tsantes 2014</a> reported an incremental cost‐effectiveness ratio (ICER) of EUR 6916 to prevent one case of FNHTR. Additionally, it is reasonable to consider other costs associated with maintaining dual inventories of leukoreduced PRBC and non‐leukoreduced PRBC. </p> <p>Finally, as leukoreduction of PRBC was shown to have no effect on preventing TRALI, death, infection and other adverse events reported by RCTs, these results have to be adequately interpreted within the context of current clinical practice which differs internationally and among populations. Other strategies might be more cost‐effective than leukoreduction in terms of avoiding adverse events related to transfusion PRBC, such as the use of restrictive transfusion triggers (<a href="./references#CD009745-bbs2-0051" title="CarsonJL , CarlessPA , HebertPC . Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database of Systematic Reviews2012, Issue 4. [DOI: 10.1002/14651858.CD002042.pub3; PUBMED: 22513904] ">Carson 2012</a>; <a href="./references#CD009745-bbs2-0091" title="RohdeJM , DimcheffDE , BlumbergN , SaintS , LangaKM , KuhnL , et al. Health care‐associated infection after red blood cell transfusion: a systematic review and meta‐analysis. JAMA2014;311(13):1317‐26. [PUBMED: 24691607] ">Rohde 2014</a>), that have shown effectiveness regardless of whether blood products are leukoreduced or not. </p> </section> </section> <section id="CD009745-sec-0102"> <h3 class="title" id="CD009745-sec-0102">Quality of the evidence</h3> <p>The body of evidence available to date does not allow a definitive conclusion to be drawn about the benefits and harms of leukoreduction. The included RCTs had important methodological limitations: 1. poor and incomplete reporting of inclusion and exclusion criteria; 2. important attrition bias due to the exclusion of many patients included, but not transfused; 3. incomplete information on allocation concealment; 4. inadequate reporting of other blood components as co‐interventions; and 5. incomplete reporting of clinical outcomes of interest. Additionally, some of the included trials showed important inconsistency in the estimates of effect. </p> </section> <section id="CD009745-sec-0103"> <h3 class="title" id="CD009745-sec-0103">Potential biases in the review process</h3> <p>We applied Cochrane systematic review methodology to the search for and selection of studies for inclusion in the review. However, despite our effort to include all published studies evaluating leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion, it is possible that not all relevant data were identified. The small number of trials identified in our review raises concerns about publication bias. In order to identify this potential bias we performed a funnel plot. However, this visual method was possible only for one outcome (infection of any cause), since fewer than 10 studies assessed the other outcomes. </p> <p>We contacted trial authors during the identification of trials (see <a href="./appendices#CD009745-sec-0121">Appendix 3</a>) to clarify some questions related to the eligibility criteria, but not while we completed data extraction and analysis. We took into account only published data during these processes, considering the missing information as reporting bias. </p> <p>In the review protocol we defined the main analysis based on the ITT approach (<a href="./references#CD009745-bbs2-0114" title="Simancas‐RacinesD , Martí‐CarvajalAJ , HidalgoR , BangdiwalaS . Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion. Cochrane Database of Systematic Reviews2012, Issue 3. [DOI: 10.1002/14651858.CD009745] ">Simancas‐Racines 2012</a>). However, during the data extraction we identified an important number of patients included but not transfused. This may affect the precision of the effect estimations. In order to explore this scenario, we carried out a per‐protocol analysis (only transfused patients) which did not reflect relevant differences in relation to the primary outcome (TRALI) and secondary outcomes death and infection from any cause, but the secondary outcome adverse events (fever) showed differences. </p> <p>A limitation of the review was not considering the effect of buffy coat depletion in the estimations through a sensitivity analysis, because we had not planned such analysis in advance. Another limitation was not considering the subgroup analysis of the potential effect of different types of filters used in the included studies for all outcomes. We planned this analysis in the review protocol only for the primary outcome. </p> </section> <section id="CD009745-sec-0104"> <h3 class="title" id="CD009745-sec-0104">Agreements and disagreements with other studies or reviews</h3> <p>Reviews and meta‐analyses on postoperative infection and death related to the leukoreduction of blood products have been carried out previously. However, as far as we know, no systematic reviews focused on non‐infectious complications, such as TRALI or FNHTR, have yet been published. In the overall analysis of death from any cause, the findings of other reviews are in accordance with our results. Nevertheless, one systematic review showed a 50% reduction in the probability of postoperative infection (<a href="./references#CD009745-bbs2-0048" title="BlumbergN , ZhaoH , WangH , MessingS , HealJM , LymanGH . The intention‐to‐treat principle in clinical trials and meta‐analyses of leukoreduced blood transfusions in surgical patients. Transfusion2007;47(4):573‐81. [PUBMED: 17381614] ">Blumberg 2007</a>) and another review analysing "only patients who received transfusion" found a statistically significant reduction of 40% in postoperative infection, but a non‐significant reduction in mortality (<a href="./references#CD009745-bbs2-0057" title="FergussonD , KhannaMP , TinmouthA , HébertPC . Transfusion of leukoreduced red blood cells may decrease postoperative infections: two meta‐analyses of randomized controlled trials. Canadian Journal of Anaesthesia (Journal Canadien d'Anesthésie)2004;51(5):417‐24. [PUBMED: 15128625] ">Fergusson 2004</a>). </p> <p>These two reviews have several limitations. They included studies with other blood components apart from leukoreduced PRBC cells as interventions, as well as non‐randomised studies. Moreover, heterogeneity between studies was not taken into account and the risk of bias of included studies was not appropriately assessed. Furthermore, some relevant studies were not included. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009745-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/urn:x-wiley:14651858:media:CD009745:CD009745-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_t/tCD009745-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD009745-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/full#CD009745-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009745-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/urn:x-wiley:14651858:media:CD009745:CD009745-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_t/tCD009745-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies." data-id="CD009745-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/full#CD009745-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009745-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/urn:x-wiley:14651858:media:CD009745:CD009745-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_t/tCD009745-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study." data-id="CD009745-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/full#CD009745-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009745-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/urn:x-wiley:14651858:media:CD009745:CD009745-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_t/tCD009745-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="TSA calculated to reliably detect a 25% relative change in the incidence of death from any cause, assuming a control group event rate of 9.34% with a power of 80% at an alpha of 5%" data-id="CD009745-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>TSA calculated to reliably detect a 25% relative change in the incidence of death from any cause, assuming a control group event rate of 9.34% with a power of 80% at an alpha of 5% </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/full#CD009745-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009745-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/urn:x-wiley:14651858:media:CD009745:CD009745-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_t/tCD009745-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Leukoreduced PRBC versus non‐leukoreduced PRBC. Main Analysis (Randomised patients), outcome: 1.3 Infection. Number of events of the total of randomised patients reported." data-id="CD009745-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Leukoreduced PRBC versus non‐leukoreduced PRBC. Main Analysis (Randomised patients), outcome: 1.3 Infection. Number of events of the total of randomised patients reported. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/full#CD009745-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009745-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/urn:x-wiley:14651858:media:CD009745:CD009745-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_t/tCD009745-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="TSA calculated to reliably detect a 25% relative change in the incidence of infection from any cause, assuming a control group event rate of 20.4% with a power of 80% at an alpha of 5%." data-id="CD009745-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>TSA calculated to reliably detect a 25% relative change in the incidence of infection from any cause, assuming a control group event rate of 20.4% with a power of 80% at an alpha of 5%. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/full#CD009745-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009745-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/urn:x-wiley:14651858:media:CD009745:CD009745-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_t/tCD009745-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="TSA calculated to reliably detect a 25% relative change in the incidence of fever, assuming a control group event rate of 38.7% with a power of 80% at an alpha of 5%." data-id="CD009745-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>TSA calculated to reliably detect a 25% relative change in the incidence of fever, assuming a control group event rate of 38.7% with a power of 80% at an alpha of 5%. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/full#CD009745-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009745-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/urn:x-wiley:14651858:media:CD009745:CD009745-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_t/tCD009745-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Leukoreduced PRBC versus non‐leukoreduced PRBC. Main analysis (randomised patients), Outcome 1 TRALI. Number of events of the total of randomised patients reported." data-id="CD009745-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Leukoreduced PRBC versus non‐leukoreduced PRBC. Main analysis (randomised patients), Outcome 1 TRALI. Number of events of the total of randomised patients reported. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/references#CD009745-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009745-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/urn:x-wiley:14651858:media:CD009745:CD009745-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_t/tCD009745-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Leukoreduced PRBC versus non‐leukoreduced PRBC. Main analysis (randomised patients), Outcome 2 Death. Number of events of the total of randomised patients reported." data-id="CD009745-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Leukoreduced PRBC versus non‐leukoreduced PRBC. Main analysis (randomised patients), Outcome 2 Death. Number of events of the total of randomised patients reported. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/references#CD009745-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009745-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/urn:x-wiley:14651858:media:CD009745:CD009745-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_t/tCD009745-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Leukoreduced PRBC versus non‐leukoreduced PRBC. Main analysis (randomised patients), Outcome 3 Infection. Number of events of the total of randomised patients reported." data-id="CD009745-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Leukoreduced PRBC versus non‐leukoreduced PRBC. Main analysis (randomised patients), Outcome 3 Infection. Number of events of the total of randomised patients reported. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/references#CD009745-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009745-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/urn:x-wiley:14651858:media:CD009745:CD009745-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_t/tCD009745-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Leukoreduced PRBC versus non‐leukoreduced PRBC. Main analysis (randomised patients), Outcome 4 Adverse events. Number of events of the total of randomised patients reported." data-id="CD009745-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Leukoreduced PRBC versus non‐leukoreduced PRBC. Main analysis (randomised patients), Outcome 4 Adverse events. Number of events of the total of randomised patients reported. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/references#CD009745-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009745-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/urn:x-wiley:14651858:media:CD009745:CD009745-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_t/tCD009745-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Leukoreduced PRBC versus non‐leukoreduced PRBC. Secondary analysis (transfused patients), Outcome 1 TRALI. Number of events of the total of transfused patients reported." data-id="CD009745-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Leukoreduced PRBC versus non‐leukoreduced PRBC. Secondary analysis (transfused patients), Outcome 1 TRALI. Number of events of the total of transfused patients reported. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/references#CD009745-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009745-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/urn:x-wiley:14651858:media:CD009745:CD009745-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_t/tCD009745-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Leukoreduced PRBC versus non‐leukoreduced PRBC. Secondary analysis (transfused patients), Outcome 2 Death. Number of events of the total of transfused patients reported." data-id="CD009745-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Leukoreduced PRBC versus non‐leukoreduced PRBC. Secondary analysis (transfused patients), Outcome 2 Death. Number of events of the total of transfused patients reported. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/references#CD009745-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009745-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/urn:x-wiley:14651858:media:CD009745:CD009745-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_t/tCD009745-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Leukoreduced PRBC versus non‐leukoreduced PRBC. Secondary analysis (transfused patients), Outcome 3 Infection. Number of events of the total of transfused patients reported." data-id="CD009745-fig-0014" src="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Leukoreduced PRBC versus non‐leukoreduced PRBC. Secondary analysis (transfused patients), Outcome 3 Infection. Number of events of the total of transfused patients reported. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/references#CD009745-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009745-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/urn:x-wiley:14651858:media:CD009745:CD009745-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_t/tCD009745-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Leukoreduced PRBC versus non‐leukoreduced PRBC. Secondary analysis (transfused patients), Outcome 4 Adverse events. Number of events of the total of transfused patients reported." data-id="CD009745-fig-0015" src="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Leukoreduced PRBC versus non‐leukoreduced PRBC. Secondary analysis (transfused patients), Outcome 4 Adverse events. Number of events of the total of transfused patients reported. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/references#CD009745-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/media/CDSR/CD009745/image_n/nCD009745-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009745-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Leukoreduced PRBCs versus non‐leukoreduced PRBCs for preventing adverse reaction from allogeneic blood transfusion</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Leukoreduced PRBCs versus non‐leukoreduced PRBCs for preventing adverse reaction from allogeneic blood transfusion</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients receiving RBC transfusion<br/> <b>Settings:</b> Any<br/> <b>Intervention:</b> Leukoreduced PRBCs<br/> <b>Comparison:</b> Non‐leukoreduced PRBCs </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Non‐leukoreduced packed RBCs</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Leukoreduced packed RBCs</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>TRALI</b> <br/> Follow‐up: mean 28 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.96</b> <br/> (0.67 to 1.36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1864<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>TSA yielded an inconclusive result.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>63 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>61 per 1000</b> <br/> (42 to 86) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Death due to any cause</b> <br/> Follow‐up: median 2.5 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.81</b> <br/> (0.58 to 1.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6485<br/> (9 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>TSA yielded an inconclusive<br/> result. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>93 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>76 per 1000</b> <br/> (54 to 104) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Infection from any cause</b> <br/> Follow‐up: mean 2.5 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.80</b> <br/> (0.62 to 1.03) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>6709<br/> (10 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>TSA yielded an inconclusive<br/> result. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>204 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>163 per 1000</b> <br/> (127 to 210) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b> <br/> Follow‐up: mean 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.81</b> <br/> (0.64 to 1.02) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>634<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>TSA yielded an inconclusive<br/> result. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>387 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>314 per 1000</b> <br/> (248 to 395) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Non‐infectious complication</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>No trial assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> was the median control group risk across studies. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>TRALI:</b> Transfusion‐related acute lung injury; <b>RBC:</b> Red blood cell; <b>PRBC:</b> Packed red blood cell; <b>DARIS:</b> Diversity‐adjusted required information size. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Downgraded by two due to imprecision: small sample size as compared with the calculated DARIS and the wide CI overlapping zones of no effect, as well as potential harm or benefit, or both. Few events reported.<br/> <sup>2</sup>Downgraded due to: high risk of bias (Six of nine included studies have high or unclear risk of bias. ‐1); important heterogeneity (I² statistic: 63%, ‐1); and imprecision as reflected in the wide CI and an insufficient accrued information size compared with the DARIS (‐1). </p> <p><sup>3</sup>Downgraded due to: high risk of bias (Seven of 10 included studies were at high or unclear risk of bias, ‐1); important heterogeneity (I² statistic: 84%, ‐2); and imprecision due to the CI crossing the threshold of meaningful effect and an insufficient sample size as compared with the DARIS (‐1) </p> <p><sup>4</sup>Downgraded due to: high risk of bias (All included studies evaluated were at high risk of bias, ‐1) and imprecision due to the CI crossing the threshold of meaningful effect and an insufficient sample size as compared with the DARIS (‐1). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Leukoreduced PRBCs versus non‐leukoreduced PRBCs for preventing adverse reaction from allogeneic blood transfusion</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/full#CD009745-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009745-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Leukoreduced PRBC versus non‐leukoreduced PRBC. Main analysis (randomised patients)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 TRALI. Number of events of the total of randomised patients reported <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1864</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.67, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Death. Number of events of the total of randomised patients reported <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6485</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.58, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Infection. Number of events of the total of randomised patients reported <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6709</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.62, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Adverse events. Number of events of the total of randomised patients reported <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>634</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.64, 1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Fever</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>634</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.64, 1.02]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Leukoreduced PRBC versus non‐leukoreduced PRBC. Main analysis (randomised patients)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/references#CD009745-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009745-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Leukoreduced PRBC versus non‐leukoreduced PRBC. Secondary analysis (transfused patients)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 TRALI. Number of events of the total of transfused patients reported <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.74, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Death. Number of events of the total of transfused patients reported <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4060</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.60, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Infection. Number of events of the total of transfused patients reported <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3557</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.58, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Adverse events. Number of events of the total of transfused patients reported <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>544</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.60, 0.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Fever</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>544</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.60, 0.94]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Leukoreduced PRBC versus non‐leukoreduced PRBC. Secondary analysis (transfused patients)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009745.pub2/references#CD009745-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009745.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD009745-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD009745-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009745-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD009745-note-0003">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ru#CD009745-note-0002">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009745\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009745\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009745\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009745\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009745\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009745\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009745\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009745\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009745\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009745\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009745\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009745\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009745\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009745\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009745\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009745\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009745\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009745\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=kKvAiZoF&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009745.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009745.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009745.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009745.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009745.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717619334"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009745.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717619338"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009745.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dbc543b9b9371',t:'MTc0MDcxNzYxOS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 